<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="research-article" dtd-version="2.3" xml:lang="EN">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Immunol.</journal-id>
<journal-title>Frontiers in Immunology</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Immunol.</abbrev-journal-title>
<issn pub-type="epub">1664-3224</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/fimmu.2022.969340</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Immunology</subject>
<subj-group>
<subject>Original Research</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>NKp46<sup>+</sup> natural killer cells develop an activated/memory-like phenotype and contribute to innate immunity against experimental filarial infection</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Pionnier</surname>
<given-names>Nicolas</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/2002956"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Furlong-Silva</surname>
<given-names>Julio</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Colombo</surname>
<given-names>Stefano A. P.</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1767859"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Marriott</surname>
<given-names>Amy E.</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Chunda</surname>
<given-names>Valerine C.</given-names>
</name>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
<xref ref-type="aff" rid="aff4">
<sup>4</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Ndzeshang</surname>
<given-names>Bertrand L.</given-names>
</name>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
<xref ref-type="aff" rid="aff4">
<sup>4</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Sjoberg</surname>
<given-names>Hanna</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Archer</surname>
<given-names>John</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Steven</surname>
<given-names>Andrew</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Wanji</surname>
<given-names>Samuel</given-names>
</name>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
<xref ref-type="aff" rid="aff4">
<sup>4</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1073694"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Taylor</surname>
<given-names>Mark J.</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1005097"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Turner</surname>
<given-names>Joseph D.</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="author-notes" rid="fn001">
<sup>*</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1015670"/>
</contrib>
</contrib-group>
<aff id="aff1">
<sup>1</sup>
<institution>Centre for Drugs and Diagnostics, Department of Parasitology, Liverpool School of Tropical Medicine</institution>, <addr-line>Liverpool</addr-line>, <country>United Kingdom</country>
</aff>
<aff id="aff2">
<sup>2</sup>
<institution>Centre for Bioscience, John Dalton Building, Faculty of Science and Engineering, Manchester Metropolitan University</institution>, <addr-line>Manchester</addr-line>, <country>United Kingdom</country>
</aff>
<aff id="aff3">
<sup>3</sup>
<institution>Parasite and Vector Biology Research Unit, Department of Microbiology and Parasitology, Faculty of Science, University of Buea</institution>, <addr-line>Buea</addr-line>, <country>Cameroon</country>
</aff>
<aff id="aff4">
<sup>4</sup>
<institution>Research Foundation for Tropical Diseases and the Environment (REFOTDE)</institution>, <addr-line>Buea</addr-line>, <country>Cameroon</country>
</aff>
<author-notes>
<fn fn-type="edited-by">
<p>Edited by: Fabrizio Bruschi, University of Pisa, Italy</p>
</fn>
<fn fn-type="edited-by">
<p>Reviewed by: Dominik R&#xfc;ckerl, The University of Manchester, United Kingdom; Vijay Kumar, Louisiana State University, United States</p>
</fn>
<fn fn-type="corresp" id="fn001">
<p>*Correspondence: Joseph D. Turner, <email xlink:href="mailto:joseph.turner@lstmed.ac.uk">joseph.turner@lstmed.ac.uk</email>
</p>
</fn>
<fn fn-type="other" id="fn002">
<p>This article was submitted to Parasite Immunology, a section of the journal Frontiers in Immunology</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>27</day>
<month>09</month>
<year>2022</year>
</pub-date>
<pub-date pub-type="collection">
<year>2022</year>
</pub-date>
<volume>13</volume>
<elocation-id>969340</elocation-id>
<history>
<date date-type="received">
<day>14</day>
<month>06</month>
<year>2022</year>
</date>
<date date-type="accepted">
<day>05</day>
<month>09</month>
<year>2022</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#xa9; 2022 Pionnier, Furlong-Silva, Colombo, Marriott, Chunda, Ndzeshang, Sjoberg, Archer, Steven, Wanji, Taylor and Turner</copyright-statement>
<copyright-year>2022</copyright-year>
<copyright-holder>Pionnier, Furlong-Silva, Colombo, Marriott, Chunda, Ndzeshang, Sjoberg, Archer, Steven, Wanji, Taylor and Turner</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p>
</license>
</permissions>
<abstract>
<p>Lymphatic filariasis and onchocerciasis are major neglected tropical diseases affecting over 90 million people worldwide with painful and profoundly disfiguring pathologies (such as lymphoedema or blindness). Type 2 inflammation is a hallmark of filarial nematode tissue infection and is implicated both in eosinophil dependent immunity and lymphatic or ocular immunopathologies. Type-2 innate lymphoid cells (ILC2) are known to play an important role in the initiation of type 2 inflammation in helminth infection. We therefore tracked comparative IL-12R&#x3b2;2<sup>+</sup> ILC1, ST2<sup>+</sup> ILC2 and NKp46<sup>+</sup> natural killer (NK) innate lymphoid cell population expansions during <italic>Brugia malayi</italic> experimental peritoneal filarial infections using either immunocompetent or immunodeficient mice. In immunocompetent BALB/c animals, NKp46<sup>+</sup> NK cells rapidly expanded representing over 90% of the ILC population in the first week of infection, whereas, surprisingly, ST2<sup>+</sup> ILC2 failed to expand. NKp46<sup>+</sup> NK cell expansions were confirmed in RAG2 deficient mice lacking adaptive immunity. Ablation of the NKp46<sup>+</sup> NK cell compartment in RAG2 common gamma chain (gc) mice led to increased susceptibility to chronic adult <italic>B. malayi</italic> infection. This data was recapitulated using an <italic>Onchocerca ochengi</italic> male worm peritoneal implant model. When NKp46<sup>+</sup> NK cells were depleted in RAG2 deficient mice using anti-NKp46 or asialo GM1 antibody injections over the first five weeks of <italic>B. malayi</italic> infection, susceptibility to adult <italic>B. malayi</italic> infection was significantly increased by 2-3 fold with concomitant impairment in eosinophil or neutrophil recruitments. Finally, we demonstrate that in RAG2 deficient mice, drug clearance of a primary adult <italic>B. malayi</italic> infection followed by challenge infection leads to resistance against early larval <italic>B. malayi</italic> establishment. This innate resistance is associated with bolstered NK and eosinophils whereby NKp46<sup>+</sup> NK cells express markers of memory-like/enhanced activation (increased expression of interferon gamma and Ly6C). Our data promotes a novel functional role for NKp46<sup>+</sup> NK cells in immunoprotection against experimental primary and secondary filarial infection which can proceed in the absence of adaptive immune regulation.</p>
</abstract>
<kwd-group>
<kwd>natural killer cells (NK cells)</kwd>
<kwd>lymphatic filariasis</kwd>
<kwd>
<italic>Brugia malayi</italic>
</kwd>
<kwd>innate lymphoid cells (ILC)</kwd>
<kwd>eosinophils</kwd>
<kwd>Rag2 knockout (KO) mouse</kwd>
<kwd>neutrophils</kwd>
</kwd-group>
<contract-sponsor id="cn001">Bill and Melinda Gates Foundation<named-content content-type="fundref-id">10.13039/100000865</named-content>
</contract-sponsor>
<counts>
<fig-count count="4"/>
<table-count count="0"/>
<equation-count count="0"/>
<ref-count count="64"/>
<page-count count="13"/>
<word-count count="5339"/>
</counts>
</article-meta>
</front>
<body>
<sec id="s1" sec-type="intro">
<title>Introduction</title>
<p>Lymphatic filariasis and onchocerciasis are parasitic helminth Neglected Tropical Diseases (NTDs) evoking severe morbidity. These filarial diseases are being prioritized for elimination. Despite encouraging results accomplished by mass drug administration programs over the last thirty years, the number of people infected with these filarial parasites remains significant in endemic regions (approximately 90 million combined) (<xref ref-type="bibr" rid="B1">1</xref>). The recent CoVID-19 pandemic significantly impacted on preventive chemotherapy treatment coverage and highlights the vulnerability of this long-term elimination strategy with preventative chemotherapy (<xref ref-type="bibr" rid="B2">2</xref>).</p>
<p>Filarial nematodes induce polarized host type 2 immune responses in experimental models which are associated with killing of developing larvae and induction of immunopathology in the lymphatics or ocular tissues (<xref ref-type="bibr" rid="B3">3</xref>, <xref ref-type="bibr" rid="B4">4</xref>). Clinically, type-2 immune responses are also evident and associated with pathology, albeit as part of a more heterogeneous immune response including induction of regulatory immune networks and classical inflammation evoked by <italic>Wolbachia</italic> endobacteria and secondary microbial skin infections (<xref ref-type="bibr" rid="B5">5</xref>&#x2013;<xref ref-type="bibr" rid="B7">7</xref>). Cellular mechanisms of type-2 anti-filarial responses include the proliferation of non-classical &#x2018;alternatively activated&#x2019; polarized macrophages at the site of infection (<xref ref-type="bibr" rid="B8">8</xref>, <xref ref-type="bibr" rid="B9">9</xref>), driving a profound chemotactic eosinophil recruitment from the blood (<xref ref-type="bibr" rid="B10">10</xref>&#x2013;<xref ref-type="bibr" rid="B13">13</xref>) which in turn leads to granulocyte-dependent larvicidal effector response and granuloma formation (<xref ref-type="bibr" rid="B14">14</xref>&#x2013;<xref ref-type="bibr" rid="B17">17</xref>). However, little is known on the pathogen sensing and sources of type-2 priming signals involved in the early stages of the infection. We have recently identified a clear IL-4/IL-13/IL-4R&#x3b1; dependent mechanism for tissue macrophages proliferation and activation (<xref ref-type="bibr" rid="B13">13</xref>). However, we have also demonstrated that there are IL-4R&#x3b1;-independent/IL-5- and CCR3-dependent pathways mechanisms that can also lead to eosinophil-dependent effector responses prior to patency (<xref ref-type="bibr" rid="B12">12</xref>), thus indicating that other early sources of Type 2 associated cytokines and ligands might be involved in this mechanism.</p>
<p>Innate lymphoid cells (ILCs) were first described as innate counterparts of T lymphocytes, being able to produce an array of effector cytokines but lacking adaptive antigen receptors (<xref ref-type="bibr" rid="B18">18</xref>, <xref ref-type="bibr" rid="B19">19</xref>). Amongst these, type 2 ILCs (ILC2) are known for producing IL-4, -5, -9 and/or -13 in the context of helminth infection (<xref ref-type="bibr" rid="B20">20</xref>, <xref ref-type="bibr" rid="B21">21</xref>) which promote CD4<sup>+</sup> T-helper (Th)2 differentiation (<xref ref-type="bibr" rid="B22">22</xref>). In addition, these cells have also been reported to proliferate in sterile tissue sites following filarial nematode infection (<xref ref-type="bibr" rid="B20">20</xref>). Recent studies have shown using RAG2<sup>-/-</sup>&#x3b3;c<sup>-/-</sup> immunodeficient animals (lacking functional lymphocytes and innate lymphoid cells) that chronic susceptibility to certain filarial infections is dependent both on lack of adaptive immune function and ablation of the ILC compartment (<xref ref-type="bibr" rid="B23">23</xref>&#x2013;<xref ref-type="bibr" rid="B25">25</xref>). Beyond ILC2s, NK cells, which belong to the ILC1 family, have also been shown to produce IL-4 and IL-5 cytokines against <italic>Brugia malayi</italic> microfilaria (<xref ref-type="bibr" rid="B26">26</xref>) and contribute to the production of IL-13 in the context of a <italic>Trichuris muris</italic> infection (<xref ref-type="bibr" rid="B27">27</xref>). Furthermore, NK cells depletion led to increased <italic>Litomosoides sigmodontis</italic> filarial worm load (<xref ref-type="bibr" rid="B28">28</xref>).</p>
<p>Our present study focused on the exploration of ST2<sup>+</sup> ILC2, IL-12R&#x3b2;2<sup>+</sup> ILC1 (non NK) and NKp46<sup>+</sup> NK cell populations dynamics and protective immune functional roles in the context of the human lymphatic filaria, <italic>B. malayi</italic>, using experimental infections of immunocompetent, RAG2<sup>-/-</sup> and RAG2<sup>-/-</sup>&#x3b3;c<sup>-/-</sup> immunodeficient animals and <italic>via</italic> antibody mediated cell depletions.</p>
</sec>
<sec id="s2" sec-type="materials|methods">
<title>Materials and methods</title>
<sec id="s2_1">
<title>Animals, infections, and treatments</title>
<p>BALB/c and BALB/c RAG2<sup>-/-</sup>&#x3b3;c<sup>-/-</sup> male mice were purchased from Charles River UK whilst BALB/c RAG2<sup>-/-</sup> mice were kindly provided by Prof Andrew McKenzie (MRC Laboratory of Molecular Biology, Cambridge University, UK) and by Prof. Dr. Antonius Rolink (Developmental and Molecular Immunology Department of Biomedicine, University of Basel, Switzerland). Mongolian gerbils <italic>(Meriones unguiculatus</italic>) were originally purchased from Charles River, Europe. BALB/c and RAG2<sup>-/-</sup> mice and gerbils were subsequently bred in house. All animals were maintained in SPF conditions at the Biological Services Unit of the University of Liverpool. The experimental life cycle of <italic>B. malayi</italic> was maintained by passage between intraperitoneal infections of male gerbils and membrane-feeding of the Liverpool <italic>Aedes aegypti</italic> mosquitoes strain, as previously described to provide infectious stage L3 larvae for infections (<xref ref-type="bibr" rid="B13">13</xref>, <xref ref-type="bibr" rid="B29">29</xref>).</p>
<p>Groups of between four and six male mice of 50-60 days of age (18-20g) were experimentally infected with 50 <italic>B. malayi</italic> L3 in a maximum volume of 200&#xb5;L of RPMI medium and inoculated <italic>via</italic> intraperitoneal injection as previously described (<xref ref-type="bibr" rid="B13">13</xref>). Mice were euthanized by UK Home Office approved schedule 1 method at given time points (days or weeks) post-infection. All experiments on animals were approved by the ethical committees of LSTM and the University of Liverpool and were conducted according to Home Office Legislation and ARRIVE guidelines.</p>
<p>In NK depletion studies, mouse groups were treated through serial IP injections with either 0.5 mg anti-NKp46 antibody (clone 9E2, Biolegend) or 0.5 mg of its isotype control (mouse IgG1, Biolegend) per mouse every 6 days until 5 weeks post-infection. Alternatively, mouse groups were also subjected to serial IP injections with 50 &#xb5;L of anti-Asialo-GM1 antibody (clone Poly21460, Biolegend) or its rabbit polyclonal IgG isotype control (Biolegend) every 4 days until 5 weeks post-infection.</p>
<p>In immune-primed studies, <italic>B. malayi</italic> infected mice were subcutaneously injected with flubendazole (Sigma) at 10 mg/kg 4 weeks post-infection. According to published protocols (<xref ref-type="bibr" rid="B30">30</xref>&#x2013;<xref ref-type="bibr" rid="B32">32</xref>) a worm infection clearance/drug washout period of 5 weeks was considered prior to mice enrolling another <italic>B. malayi</italic> infection challenge as described in the previous paragraph.</p>
<p>For <italic>Onchocerca ochengi</italic> infections CB.17 SCID (5-6 weeks of age, from Charles River Europe), RAG2<sup>-/-</sup> and RAG2<sup>-/-</sup>&#x3b3;c<sup>-/-</sup> male mice were shipped to the Research Foundation for Tropical Diseases and the Environment (REFOTDE), Buea, Cameroon maintained in individually ventilated caging (IVC) with high-efficiency particulate air (HEPA) filtered air system (Tecniplast, UK). Mice were infected with intraperitoneal <italic>O. ochengi</italic> adult worms implantations as previously described (<xref ref-type="bibr" rid="B29">29</xref>, <xref ref-type="bibr" rid="B30">30</xref>) and culled at 6 weeks post-infection. Parasites and peritoneal cell exudates were recovered and analyzed as described below. All experiments carried out in Cameroon were approved by the Animal Care Committee, REFOTDE.</p>
</sec>
<sec id="s2_2">
<title>Parasites and peritoneal exudate cell isolation</title>
<p>Motile <italic>B. malayi</italic> or <italic>O. ochengi</italic> parasites and peritoneal exudate cells (PECs) were recovered by peritoneal lavage with 10mL PBS +5% FCS at necropsy and worms were enumerated by microscopy. After parasite enumeration and removal, peritoneal exudates were centrifuged (250G, 5min, 4&#xb0;C) and cells were resuspended in 1 mL FACS buffer (PBS, 5% FCS, 1mM EDTA). Total cell counts were performed in PBS/0.04% trypan blue (Sigma) using a hemocytometer (KOVA<sup>&#xae;</sup> Glasstic Slide). Cell infiltrates were consequently phenotypically analyzed through flow cytometry.</p>
</sec>
<sec id="s2_3">
<title>Flow cytometry</title>
<p>Proportions of granulocytes (eosinophils, neutrophils) populations were determined by flow cytometry using anti-SiglecF-PE (BD, clone E50-2440) and anti-Ly6G-BV650 (Biolegend, clone 1A8) rat anti-mouse antibodies. For innate lymphoid cell populations characterization, a lineage cocktail comprised of anti-CD8 (eBioscience, clone 53-6.7), anti-B220 (eBioscience, clone RA3-6B2), anti-F4/80 (eBioscience, clone BM8), anti-SiglecF (Miltenyi Biotec, clone ES22-10D8), anti-CD4 (eBioscience, clone GK1.5), anti-Ly6G (eBioscience, clone RB6-8C5) and anti- Fc&#x190;R1 (eBioscience, clone MAR-1) antibodies conjugated to APC was used in combination with anti-ST2-PE (eBioscience, clone RMST2-2), anti-NKp46-AF700 (BD, clone 29A1.4), anti- IL-12R&#x3b2;2-AF488 (R&amp;D, clone 305719) and anti-CD127-PerCPCy5.5 (eBioscience, clone A7R34). In addition, NK cell activation was investigated using additional anti-IFN&#x3b3;- BV510 (clone XMG1.2, Biolegend) and anti-Ly6C-BV785 (clone HK1.4, Biolegend) antibodies. All panels included a viability staining using the eF450 viability dye (Invitrogen) and all antibodies were used at a 1/40 dilution. Representative gating strategy is given in <xref ref-type="supplementary-material" rid="SF1">
<bold>Supplementary Figure 1</bold>
</xref>. Flow cytometric acquisition was performed on a BD LSR II and data analyzed on FlowJo Software (version 10.0.7).</p>
</sec>
<sec id="s2_4">
<title>Statistical analysis</title>
<p>Statistical analysis was carried out using GraphPad Prism v8. Sample size, normality (Shapiro-Wilk test) and homoscedasticity (Bartlett&#x2019;s test) were tested prior to further analysis. Data from 2-3 separate experiments were pooled where possible, i.e., if variances are not significantly different. Significant differences between groups were evaluated by either unpaired T test (2 groups) or Mann-Whitney (&gt;2 groups) or Kruskal-Wallis with Dunn&#x2019;s <italic>post-hoc</italic> tests (&gt;2 groups). Significance was defined as *: p &lt; 0.05; **: p &lt; 0.01; ***: p &lt; 0.001 and ****: p &lt; 0.0001.</p>
</sec>
</sec>
<sec id="s3" sec-type="results">
<title>Results</title>
<sec id="s3_1">
<title>NKp46<sup>+</sup> NK cells are the major ILC population at the site of <italic>Brugia malayi</italic> infection</title>
<p>As prior observed (<xref ref-type="bibr" rid="B12">12</xref>, <xref ref-type="bibr" rid="B13">13</xref>), in BALB/c immunocompetent animals, parasite recovery drastically declined within the first two weeks post-<italic>B. malayi</italic> infection (approx. 30% at day 9 and 10% at day 14, <xref ref-type="fig" rid="f1">
<bold>Figure 1A</bold>
</xref>) and mice completely cleared infection before the chronic patent time-point (0% recovery at week 12, <xref ref-type="fig" rid="f1">
<bold>Figure 1A</bold>
</xref>). As ILCs can promote the initial immune response to nematode parasites (<xref ref-type="bibr" rid="B33">33</xref>, <xref ref-type="bibr" rid="B34">34</xref>), we examined the relative expansions of ILC populations at the peritoneal site of <italic>B. malayi</italic> infection. Surprisingly, we did not observe significant expansion of ST2<sup>+</sup> ILC2s at the site of infection within the first 14 days post-infection (<xref ref-type="fig" rid="f1">
<bold>Figures 1B, C</bold>
</xref>). In regard to IL-12R&#x3b2;2<sup>+</sup> ILC1s, a significant increase was apparent between D14 and D84 (<xref ref-type="fig" rid="f1">
<bold>Figures 1B, C</bold>
</xref>). In contrast, NKp46<sup>+</sup> NK cells represented the predominant ILC population in the peritoneal cavity of either na&#xef;ve or infected mice at any time point post-infection (<xref ref-type="fig" rid="f1">
<bold>Figures 1B, C</bold>
</xref>).</p>
<fig id="f1" position="float">
<label>Figure 1</label>
<caption>
<p>ILC populations dynamics at the site of <italic>Brugia malayi</italic> infection. <bold>(A)</bold> Parasite recovery in BALB/c infected mice over the time. <bold>(B)</bold> IL-12R&#x3b2;2<sup>+</sup> ILC1s (red), NKp46<sup>+</sup> NK (blue) and ST2<sup>+</sup> ILC2s (green) cell populations expansion in the peritoneal cavity of BALB/c immunocompetent mice following <italic>B. malayi</italic> infection. Kruskal-Wallis tests followed by Dunn&#x2019;s multiple comparisons tests, n=4-25, pooled experiments. Significance is given as **:p &lt; 0.01, ***:p &lt; 0.001 and ****:p &lt; 0.0001. ns, not significant. <bold>(C)</bold> Representative density plots and gating from lineage cocktail negative cells for IL-12R&#x3b2;2<sup>+</sup> ILC1s (red), NKp46<sup>+</sup> NK cells (blue) and ST2<sup>+</sup> ILC2s (green) using IL-12R&#x3b2;2, NKp46 and ST2 respective pan markers between 0 and 84 days post-infection.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fimmu-13-969340-g001.tif"/>
</fig>
</sec>
<sec id="s3_2">
<title>NKp46<sup>+</sup> NK cell impairment through &#x3b3;c deficiency is associated with increased susceptibility to filarial parasites</title>
<p>We infected RAG2<sup>-/-</sup> and RAG2<sup>-/-</sup>&#x3b3;c<sup>-/-</sup> immunodeficient and BALB/c immunocompetent mice with <italic>B. malayi</italic> infectious larvae and examined impact on NKp46<sup>+</sup> NK cell expansion within the peritoneal infection site. NKp46<sup>+</sup> NK cell expansion was intact and similar to WT mice after one-week infection in RAG2<sup>-/-</sup> mice. However, the additional ablation of &#x3b3;c cytokine signaling inhibited the typical expansion of NKp46<sup>+</sup> NK cells in the peritoneal cavity (<xref ref-type="fig" rid="f2">
<bold>Figure 2A</bold>
</xref>). BALB/c mice rapidly eliminated the parasite (4% and 1% parasite recoveries at 1 and 12 weeks p.i., respectively, <xref ref-type="fig" rid="f2">
<bold>Figure 2B</bold>
</xref>). A similar trend was observed for the RAG2 deficiency with only 20% (1/5) of the mice retaining adult <italic>B. malayi</italic> parasites by 12 week p.i. despite 86% positive infection (6/7) at 1 week p.i. (<xref ref-type="fig" rid="f2">
<bold>Figure 2B</bold>
</xref>). Combined RAG2 and &#x3b3;c impaired mice were significantly more susceptible to <italic>B. malayi</italic> larvae at one week compared with either WT or single RAG2 knockout mice (<xref ref-type="fig" rid="f2">
<bold>Figure 2B</bold>
</xref>) and the majority remained susceptible to adult infections at 12 weeks p.i. (10/13, 77%, p=0.01).</p>
<fig id="f2" position="float">
<label>Figure 2</label>
<caption>
<p>NKp46<sup>+</sup> NK cell impairment in immunodeficient mice <italic>via</italic> &#x3b3;c deficiency renders mice more susceptible to <italic>B. malayi and Onchocerca ochengi</italic> infection. <bold>(A)</bold> Temporal changes in NKp46<sup>+</sup> NK cell populations at the site of infection or <bold>(B)</bold> Parasite recovery in infected BALB/c immunocompetent, RAG2<sup>-/-</sup> and RAG2<sup>-/-</sup>&#x3b3;c<sup>-/-</sup> immunodeficient mice at either 1 or 12 weeks post- <italic>B. malayi</italic> infection. <bold>(C)</bold> NKp46<sup>+</sup> NK cell numbers at the site of infection and <bold>(D)</bold> Parasite recovery in infected SCID, NOD.SCID and NOD.SCID&#x3b3;<sup>-/-</sup> immunodeficient mice 6 weeks post- <italic>O. ochengi</italic> worm infection. Statistical significance is derived from a Kruskal-Wallis test followed by Dunn&#x2019;s multiple comparisons tests, n=5-16, two pooled experiments <italic>(B. malayi</italic>, 1wpi repeated) n=4-8, single experiment <italic>(O. ochengi</italic>). Significance is given as: *:p &lt; 0.05, **:p &lt; 0.01, ***:p &lt; 0.001.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fimmu-13-969340-g002.tif"/>
</fig>
<p>In addition, reduced numbers of NKp46<sup>+</sup> NK cells were also observed following implantation of adult male <italic>Onchocerca ochengi</italic> into the peritoneal cavity in NOD.SCID &#x3b3;c<sup>-/-</sup> mice (NSG mice) compared with either CB.17 or NOD.SCID mice (<xref ref-type="fig" rid="f2">
<bold>Figure 2C</bold>
</xref>). This was associated with an increased rate of survival of <italic>O. ochengi</italic> in NSG mice (<xref ref-type="fig" rid="f2">
<bold>Figure 2D</bold>
</xref>). These data support a hypothesis that ILC and in particular NKp46<sup>+</sup> NK cells may have a functional role in innate resistance to filarial parasites.</p>
</sec>
<sec id="s3_3">
<title>NKp46<sup>+</sup> NK cell depletion in RAG2<sup>-/-</sup> mice leads to increased filarial parasite susceptibility and impaired granulocyte recruitment to the site of infection</title>
<p>As the &#x3b3;c depletion does not only prevent NK cell and other ILC development but also impinges multiple cytokine signaling pathways, we depleted NKp46<sup>+</sup> NK cells in BALB/c RAG2<sup>-/-</sup> mice using either anti-NKp46 or an anti-asialoGM1 monoclonal antibodies, both widely used in the context of NK cell depletion (<xref ref-type="bibr" rid="B35">35</xref>&#x2013;<xref ref-type="bibr" rid="B37">37</xref>). We selected BALB/c RAG2<sup>-/-</sup> mice based on our observations that these lymphopenic mice had sufficient residual &#x3b3;c- dependent innate immune mechanisms to mediate resistance to long-term <italic>B. malayi</italic> and in order reduce redundancy of NK-independent adaptive immune pathways intact within WT mice. When RAG2<sup>-/-</sup> mice were treated with regular injections of the anti-NKp46 antibody (<xref ref-type="fig" rid="f3">
<bold>Figures 3A&#x2013;C</bold>
</xref>), a significant increase in parasite recovery was observed at 5 weeks post-treatment (14.4% <italic>vs</italic>. 5.6% respectively, p=0.05 <xref ref-type="fig" rid="f3">
<bold>Figure 3B</bold>
</xref>). This was linked to a significant decrease in NKp46<sup>+</sup> NK cell numbers (p=0.01, <xref ref-type="fig" rid="f3">
<bold>Figure 3C</bold>
</xref>) as well as a statistically significant reduction in neutrophil numbers (p=0.01, <xref ref-type="fig" rid="f3">
<bold>Figure 3C</bold>
</xref>). Consistent with these observations, a similar outcome was obtained by treating infected RAG2<sup>-/-</sup> mice with regular anti-asialoGM1 antibody (<xref ref-type="fig" rid="f3">
<bold>Figures 3D&#x2013;F</bold>
</xref>). This regime resulted in a significant difference in parasite recovery at 5 weeks post-treatment (19.2% <italic>vs.</italic> 3.8% respectively, p=0.001 <xref ref-type="fig" rid="f3">
<bold>Figure 3E</bold>
</xref>) associated with a significant reduction in NKp46<sup>+</sup> NK cell, eosinophil and neutrophil numbers (p=0.05, p=0.01 and p=0.05 respectively, <xref ref-type="fig" rid="f3">
<bold>Figure 3F</bold>
</xref>). Interestingly, a similar NK depletion performed over the first week of infection had no significant effect on parasite recovery or granulocyte recruitment (<xref ref-type="supplementary-material" rid="SF2">
<bold>Supp Figure 2</bold>
</xref>) which might indicate that a sustained expanded NK cell population over a prolonged larval development phase of <italic>B. malayi</italic> could be required to mediate significant anti-filarial immunity.</p>
<fig id="f3" position="float">
<label>Figure 3</label>
<caption>
<p>Temporal ablation of NKp46<sup>+</sup> NK cells in RAG2<sup>-/-</sup> mice leads to increased susceptibility to <italic>B. malayi</italic> and impaired granulocytes recruitment to the site of infection. <bold>(A)</bold> Schematic representation of the study design where <italic>B. malayi</italic> infected RAG2<sup>-/-</sup> mice were intraperitoneally (IP) injected with 0,5mg anti-NKp46 antibody or its isotype control every 6 days until 5 weeks post-infection. <bold>(B)</bold> Parasite recovery in isotype control treated mice (Iso) or anti-NKp46 treated mice (Rx) at 5 weeks post-infection. <bold>(C)</bold> Innate lymphoid cells (IL-12R&#x3b2;2<sup>+</sup> ILC1, NKp46<sup>+</sup> NK, ST2<sup>+</sup> ILC2) and granulocytes (eosinophils &#x2013; Eos and neutrophils &#x2013; Neu) numbers in the peritoneal cavity of control (Iso) or anti-NKp46 treated (Rx) infected mice at 5 weeks post-infection. <bold>(D&#x2013;F)</bold> similar study in which <italic>B. malayi</italic> infected RAG2<sup>-/-</sup> mice were IP injected with 50&#xb5;L of anti-asialoGM1 antibody or its isotype control every 4 days until 5 weeks post-infection. Respective parasite recovery is given in <bold>(E)</bold> and peritoneal cell numbers in <bold>(F)</bold>. Unpaired T-tests, n=5-10, single experiment. Significance is given as *:p &lt; 0.05, **:p &lt; 0.01 and ***:p &lt; 0.001.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fimmu-13-969340-g003.tif"/>
</fig>
</sec>
<sec id="s3_4">
<title>A NKp46<sup>+</sup> NK cell enhanced activation/memory phenotype is apparent in immune-primed challenged mice</title>
<p>A memory-like phenotypic response can be elicited by a variety of innate immune cells when the immune system is primed either <italic>in vivo</italic> or <italic>in vitro</italic> (<xref ref-type="bibr" rid="B38">38</xref>). In addition, there is evidence that ILCs and especially NK cell-mediated immune responses share common features with adaptive immunity, and that these cells acquire immunological memory in a similar manner to T and B cells (<xref ref-type="bibr" rid="B39">39</xref>, <xref ref-type="bibr" rid="B40">40</xref>). We thus investigated the activation and memory-like properties of NKp46<sup>+</sup> NK cells in an immune-primed context where 4-week <italic>B. malayi</italic>-infected mice were treated with flubendazole at 10mg/kg to clear infections before being re-infected 5 weeks later with <italic>B. malayi</italic> larvae and culled 2 weeks post-infection (<xref ref-type="fig" rid="f4">
<bold>Figure 4A</bold>
</xref>). Secondary infected mice were more resistant to <italic>B. malayi</italic> challenge (17.5% <italic>vs</italic>. 3.75%, p=0.0001 <xref ref-type="fig" rid="f4">
<bold>Figure 4B</bold>
</xref>) and this was associated with a significant increase in eosinophil numbers (p=0.05, <xref ref-type="fig" rid="f4">
<bold>Figure 4C</bold>
</xref>). Interestingly, this was also accompanied with increased peritoneal NKp46<sup>+</sup> NK cell numbers (p=0.05, <xref ref-type="fig" rid="f4">
<bold>Figure 4C</bold>
</xref>) displaying significant changes in activation markers such as an enriched IFN&#x3b3; content (p=0.0001, <xref ref-type="fig" rid="f4">
<bold>Figures 4D, F</bold>
</xref>) and a marked Ly6C<sup>high</sup> phenotype (p=0.0001, <xref ref-type="fig" rid="f4">
<bold>Figures 4E, F</bold>
</xref>).</p>
<fig id="f4" position="float">
<label>Figure 4</label>
<caption>
<p>NKp46<sup>+</sup> NK cells display signs of enhanced/memory-like activation and boost anti-filarial immune response in challenge after immune-priming. <bold>(A)</bold> Schematic representation of the study design where <italic>B. malayi</italic> infected RAG2<sup>-/-</sup> mice were treated with flubendazole at 10mg/kg 4 weeks post-infection to clear them out of remaining worms before being challenged again at week 9 with <italic>B. malayi</italic> parasites and a readout 2 weeks post-challenge. <bold>(B)</bold> Parasite recovery in infected control mice (IC, clear) or primed treated infected (PTI, green) mice 2 weeks post-challenge. <bold>(C)</bold> Innate lymphoid cells (IL-12R&#x3b2;2<sup>+</sup> ILC1, NKp46<sup>+</sup> NK, ST2<sup>+</sup> ILC2) and granulocytes (eosinophils &#x2013; Eos and neutrophils &#x2013; Neu) numbers in the peritoneal cavity of infected control (IC, clear) or primed treated infected (PTI, green) mice at 2 weeks post-challenge. <bold>(D)</bold> IFN&#x3b3; content expressed as MFI in peritoneal NKp46<sup>+</sup> NK cells from IC (clear) or PTI (green) mice 2 weeks post-challenge. <bold>(E)</bold> Ly6C<sup>high</sup> NKp46<sup>+</sup> NK cell numbers in the peritoneal cavity of IC (clear) or PTI (green) mice at readout. <bold>(F)</bold> Representative histograms and flow plots for IFN and Ly6C expression or cell counts on either pre-gated NK cells or depending on NKp46 expression in IC and PTI mice at readout. Unpaired T-tests, n=4, single experiment. Significance is given as *:p &lt; 0.05 and ****:p &lt; 0.0001.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fimmu-13-969340-g004.tif"/>
</fig>
</sec>
</sec>
<sec id="s4" sec-type="discussion">
<title>Discussion</title>
<p>Infection with filarial nematodes remains a major cause of global morbidity <italic>via</italic> induction of immunopathology. Further, chronic filarial nematode infection modulates immune responses in the context of co-infection, allergy, and autoimmune disease (<xref ref-type="bibr" rid="B41">41</xref>), yet our understanding of the fundamental cellular mechanisms of immunity during infection is limited. We have previously demonstrated, through the use of RAG-deficient and SCID mice, a pivotal role for the innate compartment in the immunological control of filarial parasite infection (<xref ref-type="bibr" rid="B13">13</xref>, <xref ref-type="bibr" rid="B25">25</xref>). However, the relative contributions made by specific innate cell populations is poorly understood. The data presented here provides the first evidence of a major role for NKp46<sup>+</sup> NK cells in protection against <italic>B. malayi</italic> and <italic>O. ochengi</italic> infection in immunocompromised animals. NKp46<sup>+</sup> cells expanded rapidly during the early stages of the infection and their depletion, <italic>via</italic> the use of &#x3b3;c<sup>-/-</sup> animals and neutralizing antibodies, rendered mice susceptible to chronic infection. We also demonstrated that these cells further expand and exhibit an activated/memory-like phenotype associated with an augmented innate immune protection against <italic>B. malayi</italic> challenge infection in the absence of adaptive immunity.</p>
<p>There is a well-established role for NK cells in the defense against infection by viral, bacterial, and protozoan organisms (<xref ref-type="bibr" rid="B42">42</xref>). In these contexts, NK cells act as rapid first responders, with key roles in the production of cytokines and the direct lysis of cells. However, their role in defense against macroparasites is poorly defined. In previous studies investigating permissiveness of filarial infection in immune-deficient mouse strains, it was noted that depleting NK cells resulted in reduced <italic>B. malayi</italic> burden in C57BL/6-<italic>scid/scid</italic> mice (<xref ref-type="bibr" rid="B43">43</xref>). Complementary to this was the observation that enhancing NK cell activation, <italic>via</italic> injection with the TLR agonist poly(I:C), increased the permissiveness of NOD/LtSz-<italic>scid/scid</italic> mice (which normally show low NK cell activity and complement deficiency) to <italic>B. malayi</italic> infection (<xref ref-type="bibr" rid="B43">43</xref>). This suggested that the level of NK cell activity positively correlated with the permissiveness of the host to infection. However, in a study using BALB/c mice infected with <italic>L. sigmodontis</italic>, NK cells (identified as Dx5<sup>+</sup>CD3<sup>-</sup>) expanded significantly from 35 days post infection in the pleural cavity and down-regulated the inhibitory receptors Ly6C, Ly6A and Ly6G2, suggesting they are functioning here as effector cells rather than immunoregulators (<xref ref-type="bibr" rid="B28">28</xref>). Furthermore, their depletion with anti-asialoGM antibody increased both adult and mf burdens indicating that NK cells have an anti-filarial effect. In addition, <italic>ex vivo</italic> culture of NK cells (identified as CD3<sup>-</sup>CD56<sup>+</sup>) with <italic>B. malayi</italic> mf and L3 resulted in a contact-dependent increase in expression of the activation markers CD69 and CD71 and the pro-inflammatory cytokines IFN&#x3b3; and TNF&#x3b1; (<xref ref-type="bibr" rid="B26">26</xref>). These data indicate that NK cells respond to filarial infection by homing to the site of infection and increasing their activation state in a manner that is detrimental to the survival of the parasite. This is consistent with our data showing that depletion of NKp46<sup>+</sup> NK cells is sufficient to increase susceptible to <italic>B. malayi</italic> infection in the absence of adaptive immunity. We expanded these observations by demonstrating NKp46<sup>+</sup> NK cells developed an enhanced activation phenotype/memory-like capacity within the peritoneal cavity which was associated with innate immunological resistance against subsequent challenge following anthelmintic drug clearance of the primary infection. Such a phenomenon of &#x2018;innate resistance&#x2019; has been prior described for challenge infection with <italic>Onchocerca lienalis</italic> skin mf infection following microfilaricidal drug clearance in lymphopenic SCID mice (<xref ref-type="bibr" rid="B44">44</xref>). This apparent NKp46<sup>+</sup> cell-intrinsic memory-like phenotype and its contribution to the resistance to filarial infection requires further interrogation, using, for instance, adoptive transfer and recall activation assays.</p>
<p>The mechanism by which NKp46<sup>+</sup> NK cells mediate parasite reduction remains unclear. In previous publications we have demonstrated that eosinophils are larvicidal effector cells during <italic>B. malayi</italic> infection, and that their IL-5-/CCR3-dependent recruitment is essential for parasite expulsion in immuno-competent BALB/c mice (<xref ref-type="bibr" rid="B12">12</xref>, <xref ref-type="bibr" rid="B13">13</xref>). It was observed that in susceptible immunocompromised RAG2<sup>-/-</sup>&#x3b3;c<sup>-/-</sup> mice, which lack a functional NK cell compartment as well as being deficient in T and B cells, the granulocyte population in the peritoneal cavity during <italic>L. sigmodontis</italic> infection skewed toward neutrophils when compared to immunocompetent mice in which eosinophils predominate (<xref ref-type="bibr" rid="B23">23</xref>). Since then models of adoptive immune cell transfer into RAG2IL-2R&#x3b3;-deficient C57BL/6 mice have been developed, allowing for further pin-pointing of cellular mechanisms of anti-filarial immunity (<xref ref-type="bibr" rid="B24">24</xref>). We observed that when NKp46<sup>+</sup> NK cells were depleted using an anti-asialoGM1 antibody, eosinophil but also neutrophil recruitment to the peritoneal cavity was reduced. Thus, in the absence of an intact type-2 adaptive immune response, NKp46<sup>+</sup> NK cells may facilitate filarial larval parasite killing by co-ordinating the recruitment and activation of eosinophil and/or neutrophil effector cells alongside with subsequent granuloma formation and extracellular traps release (<xref ref-type="bibr" rid="B17">17</xref>, <xref ref-type="bibr" rid="B45">45</xref>, <xref ref-type="bibr" rid="B46">46</xref>). However, with recent reports on the anti-asialoGM1 antibody also having off-target effects on <italic>in vivo</italic> basophil populations (<xref ref-type="bibr" rid="B47">47</xref>) and on the use of anti-NKp46 antibody resulting in blocked activation rather than cellular depletion (<xref ref-type="bibr" rid="B48">48</xref>), further investigations are needed to assess ILC activation in the context of these NK depletion studies. Regarding off-target effects of anti-asioloGM1 on basophils, we and others have demonstrated that eosinophils rather than basophils are the major effector cell-type mediating attrition of filarial infections in experimental models and that basophils play a negligible role in filarial immunity (<xref ref-type="bibr" rid="B12">12</xref>, <xref ref-type="bibr" rid="B13">13</xref>, <xref ref-type="bibr" rid="B49">49</xref>). Thus, it is doubtful that anti-asioloGM1 treatment is increasing susceptibility <italic>via</italic> and off-target depletion of this granulocyte population.</p>
<p>Beyond parasitic infection, there is a clear link between NK cell activity and regulation of eosinophilia during airway hypersensitivity reactions. In humans suffering from severe asthma, NK cell activation measured by expression of CD69 and NKG2D correlated strongly with blood eosinophilia (<xref ref-type="bibr" rid="B50">50</xref>). Consistent with a role for NK cells as drivers of the eosinophilic response, in mouse models of allergic inflammation sensitization challenge with ovalbumin (OVA) resulted in a concomitant increase in NK cells and eosinophils (<xref ref-type="bibr" rid="B51">51</xref>, <xref ref-type="bibr" rid="B52">52</xref>). Further, when NK cells were depleted prior to sensitization, lung eosinophilia was impaired (<xref ref-type="bibr" rid="B51">51</xref>, <xref ref-type="bibr" rid="B52">52</xref>). <italic>In vitro</italic> co-culture of NK cells and eosinophils demonstrated that activated NK cells are capable of triggering eosinophil degranulation (<xref ref-type="bibr" rid="B53">53</xref>). Interestingly, NK cells have also been shown to act as negative regulators of eosinophils, capable of triggering their apoptosis under <italic>in vitro</italic> co-culture conditions (<xref ref-type="bibr" rid="B50">50</xref>, <xref ref-type="bibr" rid="B53">53</xref>). Further, depletion of NK cells using anti-asialoGM1 at the peak of OVA-induced airway inflammation delayed the resolution of lung eosinophilia (<xref ref-type="bibr" rid="B54">54</xref>). Thus, under type-2 inflammatory conditions, NK cells perform a dual function first recruiting eosinophils and then subsequently inducing their apoptosis to resolve inflammation. Therefore, it will be interesting to define the mode through which NKp46<sup>+</sup> NK cells recruit eosinophils during filarial infection, whether this is direct, <italic>via</italic> the secretion of chemoattractant, or if they support the development of M2 macrophages known to be key recruiters of eosinophils during <italic>B. malayi</italic> infection (<xref ref-type="bibr" rid="B13">13</xref>). There is also some evidence that NK cells express IL-5 in response to contact with <italic>B. malayi</italic> mf (<xref ref-type="bibr" rid="B26">26</xref>). However, this data was derived from a single <italic>ex vivo</italic> co-culture model of NK cell-<italic>B. malayi</italic> mf interaction. Additionally, <italic>B. malayi</italic> L3 did not provoke an IL-5 response under the same conditions. Therefore, further work is required to determine whether NK cell-secreted IL-5 is a direct recruiter of eosinophils during <italic>in vivo</italic> infection.</p>
<p>Our data illustrated a lack of ST2<sup>+</sup> ILC2 expansion in the peritoneal infection site following <italic>B. malayi</italic> infection, which was surprising given the predominant protective type-2 polarized immune response triggered in this filarial experimental infection model (<xref ref-type="bibr" rid="B12">12</xref>, <xref ref-type="bibr" rid="B13">13</xref>). In murine models of small intestinal-dwelling nematodes, ILC2s are known to play a role in the priming of Th2 responses, functioning as potent producers of Th2 cytokines (<xref ref-type="bibr" rid="B55">55</xref>). Depletion of ILC2s results in a failure to expel <italic>Nippostrongylus brasiliensis</italic> (<xref ref-type="bibr" rid="B34">34</xref>, <xref ref-type="bibr" rid="B56">56</xref>), and impairs IL-4-driven differentiation of Th2 CD4<sup>+</sup> T cells following infection with <italic>Heligmosomoides bakeri</italic> (<xref ref-type="bibr" rid="B22">22</xref>). Further, priming of ILC2s in the gut, <italic>via</italic> infection with <italic>H. bakeri</italic> or <italic>T. spiralis</italic>, can trigger ILC2 migration to distal tissues such as the lung and enhances subsequent larval trapping during the lung migratory stage of <italic>N. brasiliensis</italic> (<xref ref-type="bibr" rid="B57">57</xref>, <xref ref-type="bibr" rid="B58">58</xref>). However, the role of ILC2s during filarial nematode infection remains poorly understood. During <italic>Loa</italic> infection in humans, the frequencies of cKit<sup>+</sup>ILCs (ILC2s and ILC3s) and cKit<sup>+</sup>IL-13<sup>+</sup>ILCs (ILC2s) in peripheral blood were observed to increase (<xref ref-type="bibr" rid="B59">59</xref>). The cKit<sup>+</sup>ILCs expressed an array of TLRs and were capable of producing Th1, Th2, and Th17 cytokines upon stimulation by cytokine cocktail <italic>ex vivo.</italic> Interestingly, cKit<sup>+</sup>IL-13<sup>+</sup>ILC frequency did not correlate with the frequency of Th2 CD4<sup>+</sup>T cells suggesting that ILC2s might not be required for sustaining peripheral Th2 responses (<xref ref-type="bibr" rid="B59">59</xref>). However, the authors derived samples from already chronically infected individuals and therefore this data does not rule out a role for ILC2s in the early induction of Th2 CD4<sup>+</sup>T cell responses. Despite ST2 being expressed by a subset of ILC2s only (<xref ref-type="bibr" rid="B18">18</xref>), during chronic infection of <italic>L. sigmodontis</italic> infection in Balb/c mice, efficient clearance of <italic>L. sigmodontis</italic> microfilariae is ST2 (IL-33R)-dependent, which might implicate a role for ST2-dependent ILC2 expansion in the control of filarial microfilaremias (<xref ref-type="bibr" rid="B60">60</xref>). It has been demonstrated that IL-5 producing ILC2s expanded specifically in the pleural cavity infection site of <italic>L. sigmodontis</italic>, whereas in secondary lymphoid tissue no change in ILC2 frequency is observed (<xref ref-type="bibr" rid="B20">20</xref>). Further, the frequency of ILC2s in the blood reduces during <italic>L. sigmodontis</italic> infection (<xref ref-type="bibr" rid="B20">20</xref>), indicating that an increase in ILC2 frequency in the pleural cavity may be a consequence of recruitment from peripheral tissues. The ILC2 expansion following <italic>L. sigmodontis</italic> but not <italic>B. malayi</italic> infection in serous cavities might be explained by the <italic>L. sigmodontis</italic> larvae migration through the lymphatics and pulmonary blood vessels before the thoracic cavity invasion (<xref ref-type="bibr" rid="B61">61</xref>). Conversely, in our studies, <italic>B. malayi</italic> larvae are introduced directly into the peritoneal cavity. Considerable damages to the endothelium and lung parenchyma are evidenced as part of the <italic>L. sigmodontis</italic> larval migration route. Damaged tissues caused by nematode invasion are known to trigger a variety of &#x2018;alarmin&#x2019; release from stromal cells, such as IL-33, which are key triggers of robust ILC2 expansion (<xref ref-type="bibr" rid="B62">62</xref>).</p>
<p>Consistent with our data however, ILC2s are not ubiquitously required for immune control of all nematode parasites. Whilst ILC2s respond strongly to small intestinal nematodes (<xref ref-type="bibr" rid="B22">22</xref>, <xref ref-type="bibr" rid="B34">34</xref>, <xref ref-type="bibr" rid="B56">56</xref>) they fail to expand during infection with the cecal dwelling <italic>Trichuris muris</italic> and their depletion has no effect on parasite expulsion (<xref ref-type="bibr" rid="B63">63</xref>). Thus, it seems that the role of ILC2s in nematode infection is highly contextual and further work is required to establish causality between ILC2 activation and immunity to filarial nematodes, especially considering the diversity of clinically and veterinary important filarial nematodes and variability in their migration routes and adult niches of parasitism.</p>
<p>The present study implicates a functional role for NKp46<sup>+</sup> NK cells in innate anti-filarial immune-protection in the absence of adaptive immunity. This mechanism may be relevant in situations whereby adaptive immunity is impaired, anergized or actively suppressed (for instance genetic variability or chronic co-infection situations in humans). Further, our data provides a mechanistic rationale why additional common gamma-chain deficiency is a requirement for chronic susceptibility in lymphopenic mouse models of human/veterinary filarial pathogens.</p>
<p>Follow-up investigations are needed to demonstrate their functional interplay with effector cells such as eosinophils and the full repertoire of memory-like signals harbored by NKp46<sup>+</sup> NK cells following a secondary infection which may exert a degree of innate-memory protection from challenge. Research on NK cell biology and plasticity is progressing and reveals a wider scope of NK cell functional fates than initially thought (<xref ref-type="bibr" rid="B18">18</xref>, <xref ref-type="bibr" rid="B64">64</xref>). Selecting the relevant phenotypic markers will be therefore crucial to allow a comprehensive scrutinization of the relevant NK subsets and their dynamics following filarial primary or secondary infection.</p>
</sec>
<sec id="s5" sec-type="data-availability">
<title>Data availability statement</title>
<p>The original contributions presented in the study are included in the article/<xref ref-type="supplementary-material" rid="SF1">
<bold>Supplementary Material</bold>
</xref>. Further inquiries can be directed to the corresponding author.</p>
</sec>
<sec id="s6" sec-type="ethics-statement">
<title>Ethics statement</title>
<p>The animal study was reviewed and approved by the Liverpool School of Tropical Medicine ethical committee, the University of Liverpool ethical committee and the REFOTDE Animal Care Committee.</p>
</sec>
<sec id="s7" sec-type="author-contributions">
<title>Author contributions</title>
<p>Conceived and designed the analysis: NP, SW, MT, and JT. Collected the data: NP, JF-S, AM, VC, BN, HS, JA, and AS Contributed data or analysis tools: NP, JF-S, SC, AM, HS, SW, and JT. Performed the analysis: NP and JF-S. Wrote the paper: NP, JF-S, SC, and JT. All authors contributed to the article and approved the submitted version.</p>
</sec>
<sec id="s8" sec-type="funding-information">
<title>Funding</title>
<p>This work was supported by a Bill and Melinda Gates Foundations Grand Challenges Explorations grant (OPP1119043) to JT, SW, and MT, and a Medical Research Council New Investigator Research Grant (MR/L018756/1) to JT. The funding bodies had no roles in the design of the study and collection, analysis, and interpretation of data. This work was supported, in whole or in part, by the Bill &amp; Melinda Gates Foundation [OPP1119043]. Under the grant conditions of the Foundation, a Creative Commons Attribution 4.0 Generic License has already been assigned to the Author Accepted Manuscript version that might arise from this submission.</p>
</sec>
<sec id="s9" sec-type="COI-statement">
<title>Conflict of interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec id="s10" sec-type="disclaimer">
<title>Publisher&#x2019;s note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
</body>
<back>
<sec id="s11" sec-type="supplementary-material">
<title>Supplementary material</title>
<p>The Supplementary Material for this article can be found online at: <ext-link ext-link-type="uri" xlink:href="https://www.frontiersin.org/articles/10.3389/fimmu.2022.969340/full#supplementary-material">https://www.frontiersin.org/articles/10.3389/fimmu.2022.969340/full#supplementary-material</ext-link>
</p>
<supplementary-material xlink:href="Image_1.tif" id="SF1" mimetype="image/tiff">
<label>Supplementary Figure 1</label>
<caption>
<p>Flow cytometry gating strategy for leucocytes immunophenotyping. Doublets <bold>(A)</bold>, debris <bold>(B)</bold> and dead cells <bold>(C)</bold> were excluded and pan markers antibodies were utilised for the different cell populations. <bold>(D)</bold> Eosinophils and neutrophils were gated as SiglecF<sup>+</sup> Ly6G<sup>-</sup> and SiglecF<sup>-</sup> Ly6G<sup>+</sup> respectively. Innate lymphoid cells <bold>(E&#x2013;H)</bold> were pre-gated on lineage negative cell populations <bold>(E)</bold> (CD8<sup>-</sup>, B220<sup>-</sup>, F4/80<sup>-</sup>, SiglecF<sup>-</sup>, CD4<sup>-</sup>, Ly6G<sup>-</sup>, Fc&#x3b3;R1<sup>-</sup>) and identified as CD127<sup>-/low</sup>IL-12R&#x3b2;2<sup>+</sup>ST2<sup>-</sup>NKp46<sup>-</sup> for ILC1s <bold>(F)</bold>, CD127<sup>low</sup>IL-12R&#x3b2;2<sup>-</sup>ST2<sup>+</sup>NKp46<sup>-</sup> for ILC2s <bold>(G)</bold> and CD127<sup>-/low</sup>IL-12R&#x3b2;2<sup>-</sup>ST2<sup>-</sup>NKp46<sup>+</sup> for NK cells <bold>(H)</bold>.</p>
</caption>
</supplementary-material>
<supplementary-material xlink:href="Image_2.tif" id="SF2" mimetype="image/tiff">
<label>Supplementary Figure 2</label>
<caption>
<p>Short-term temporal ablation of NKp46<sup>+</sup> NK cells in RAG2<sup>-/-</sup> mice is not sufficient to confer treated mice an increased susceptibility to <italic>B. malayi</italic> parasites. <italic>B. malayi</italic> infected RAG2<sup>-/-</sup> mice were intraperitoneally injected with 0,5mg anti-NKp46 antibody or its isotype control in two occasions (at day 0 and day 3 post-infection) and culled at 1 week post-infection. <bold>(A)</bold> Parasite recovery in isotype control treated mice (Iso) or anti-NKp46 treated mice (Rx) at readout. <bold>(B)</bold> Innate lymphoid cells (IL-12R&#x3b2;2<sup>+</sup> ILC1, NKp46<sup>+</sup> NK, ST2<sup>+</sup> ILC2) and granulocytes (eosinophils &#x2013; Eos and neutrophils &#x2013; Neu) numbers in the peritoneal cavity of control (Iso) or anti-NKp46 treated (Rx) infected mice at readout. Unpaired T-tests, <bold>n=5</bold>, single experiment. Significance is given as *: p &lt;0.05.</p>
</caption>
</supplementary-material>
</sec>
<ref-list>
<title>References</title>
<ref id="B1">
<label>1</label>
<citation citation-type="book">
<person-group person-group-type="author">
<collab>World Health Organization</collab>
</person-group>. <article-title>Global programme to eliminate lymphatic filariasis: Progress report, 2018</article-title>. In: <source>Weekly epidemiological record</source> <volume>94</volume>. p. <page-range>457&#x2013;70</page-range>. Available at: <uri xlink:href="https://www.who.int/publications/i/item/who-wer9441-457-472">https://www.who.int/publications/i/item/who-wer9441-457-472</uri>
</citation>
</ref>
<ref id="B2">
<label>2</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Prada</surname> <given-names>JM</given-names>
</name>
<name>
<surname>Stolk</surname> <given-names>WA</given-names>
</name>
<name>
<surname>Davis</surname> <given-names>EL</given-names>
</name>
<name>
<surname>Touloupou</surname> <given-names>P</given-names>
</name>
<name>
<surname>Sharma</surname> <given-names>S</given-names>
</name>
<name>
<surname>Mu&#xf1;oz</surname> <given-names>J</given-names>
</name>
<etal/>
</person-group>. <article-title>Delays in lymphatic filariasis elimination programmes due to COVID-19, and possible mitigation strategies</article-title>. <source>Trans R Soc Trop Med Hygiene</source> (<year>2021</year>) <volume>115</volume>:<page-range>261&#x2013;8</page-range>. doi: <pub-id pub-id-type="doi">10.1093/trstmh/trab004</pub-id>
</citation>
</ref>
<ref id="B3">
<label>3</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pearlman</surname> <given-names>E</given-names>
</name>
<name>
<surname>Lass</surname> <given-names>JH</given-names>
</name>
<name>
<surname>Bardenstein</surname> <given-names>DS</given-names>
</name>
<name>
<surname>Kopf</surname> <given-names>M</given-names>
</name>
<name>
<surname>Hazlett</surname> <given-names>FE</given-names>
<suffix>Jr.</suffix>
</name>
<name>
<surname>Diaconu</surname> <given-names>E</given-names>
</name>
<etal/>
</person-group>. <article-title>Interleukin 4 and T helper type 2 cells are required for development of experimental onchocercal keratitis (river blindness)</article-title>. <source>J Exp Med</source> (<year>1995</year>) <volume>182</volume>:<page-range>931&#x2013;40</page-range>. doi: <pub-id pub-id-type="doi">10.1084/jem.182.4.931</pub-id>
</citation>
</ref>
<ref id="B4">
<label>4</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Furlong-Silva</surname> <given-names>J</given-names>
</name>
<name>
<surname>Cross</surname> <given-names>SD</given-names>
</name>
<name>
<surname>Marriott</surname> <given-names>AE</given-names>
</name>
<name>
<surname>Pionnier</surname> <given-names>N</given-names>
</name>
<name>
<surname>Archer</surname> <given-names>J</given-names>
</name>
<name>
<surname>Steven</surname> <given-names>A</given-names>
</name>
<etal/>
</person-group>. <article-title>Tetracyclines improve experimental lymphatic filariasis pathology by disrupting interleukin-4 receptor-mediated lymphangiogenesis</article-title>. <source>J Clin Invest</source> (<year>2021</year>) <volume>131</volume>:<elocation-id>e140853</elocation-id>. doi: <pub-id pub-id-type="doi">10.1172/JCI140853</pub-id>
</citation>
</ref>
<ref id="B5">
<label>5</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Babu</surname> <given-names>S</given-names>
</name>
<name>
<surname>Nutman</surname> <given-names>TB</given-names>
</name>
</person-group>. <article-title>Immunology of lymphatic filariasis</article-title>. <source>Parasite Immunol</source> (<year>2014</year>) <volume>36</volume>:<page-range>338&#x2013;46</page-range>. doi: <pub-id pub-id-type="doi">10.1111/pim.12081</pub-id>
</citation>
</ref>
<ref id="B6">
<label>6</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tamarozzi</surname> <given-names>F</given-names>
</name>
<name>
<surname>Halliday</surname> <given-names>A</given-names>
</name>
<name>
<surname>Gentil</surname> <given-names>K</given-names>
</name>
<name>
<surname>Hoerauf</surname> <given-names>A</given-names>
</name>
<name>
<surname>Pearlman</surname> <given-names>E</given-names>
</name>
<name>
<surname>Taylor</surname> <given-names>MJ</given-names>
</name>
</person-group>. <article-title>Onchocerciasis: the role of wolbachia bacterial endosymbionts in parasite biology, disease pathogenesis, and treatment</article-title>. <source>Clin Microbiol Rev</source> (<year>2011</year>) <volume>24</volume>:<page-range>459&#x2013;68</page-range>. doi: <pub-id pub-id-type="doi">10.1128/CMR.00057-10</pub-id>
</citation>
</ref>
<ref id="B7">
<label>7</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Turner</surname> <given-names>JD</given-names>
</name>
<name>
<surname>Langley</surname> <given-names>RS</given-names>
</name>
<name>
<surname>Johnston</surname> <given-names>KL</given-names>
</name>
<name>
<surname>Gentil</surname> <given-names>K</given-names>
</name>
<name>
<surname>Ford</surname> <given-names>L</given-names>
</name>
<name>
<surname>Wu</surname> <given-names>B</given-names>
</name>
<etal/>
</person-group>. <article-title>Wolbachia lipoprotein stimulates innate and adaptive immunity through toll-like receptors 2 and 6 to induce disease manifestations of filariasis</article-title>. <source>J Biol Chem</source> (<year>2009</year>) <volume>284</volume>:<page-range>22364&#x2013;78</page-range>. doi: <pub-id pub-id-type="doi">10.1074/jbc.M901528200</pub-id>
</citation>
</ref>
<ref id="B8">
<label>8</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Babu</surname> <given-names>S</given-names>
</name>
<name>
<surname>Kumaraswami</surname> <given-names>V</given-names>
</name>
<name>
<surname>Nutman</surname> <given-names>TB</given-names>
</name>
</person-group>. <article-title>Alternatively activated and immunoregulatory monocytes in human filarial infections</article-title>. <source>J Infect Dis</source> (<year>2009</year>) <volume>199</volume>:<page-range>1827&#x2013;37</page-range>. doi: <pub-id pub-id-type="doi">10.1086/599090</pub-id>
</citation>
</ref>
<ref id="B9">
<label>9</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Taylor</surname> <given-names>MD</given-names>
</name>
<name>
<surname>Harris</surname> <given-names>A</given-names>
</name>
<name>
<surname>Nair</surname> <given-names>MG</given-names>
</name>
<name>
<surname>Maizels</surname> <given-names>RM</given-names>
</name>
<name>
<surname>Allen</surname> <given-names>JE</given-names>
</name>
</person-group>. <article-title>F4/80+ alternatively activated macrophages control CD4+ T cell hyporesponsiveness at sites peripheral to filarial infection</article-title>. <source>J Immunol</source> (<year>2006</year>) <volume>176</volume>:<page-range>6918&#x2013;27</page-range>. doi: <pub-id pub-id-type="doi">10.4049/jimmunol.176.11.6918</pub-id>
</citation>
</ref>
<ref id="B10">
<label>10</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cadman</surname> <given-names>ET</given-names>
</name>
<name>
<surname>Thysse</surname> <given-names>KA</given-names>
</name>
<name>
<surname>Bearder</surname> <given-names>S</given-names>
</name>
<name>
<surname>Cheung</surname> <given-names>AY</given-names>
</name>
<name>
<surname>Johnston</surname> <given-names>AC</given-names>
</name>
<name>
<surname>Lee</surname> <given-names>JJ</given-names>
</name>
<etal/>
</person-group>. <article-title>Eosinophils are important for protection, immunoregulation and pathology during infection with nematode microfilariae</article-title>. <source>PloS Pathog</source> (<year>2014</year>) <volume>10</volume>:<elocation-id>e1003988</elocation-id>. doi: <pub-id pub-id-type="doi">10.1371/journal.ppat.1003988</pub-id>
</citation>
</ref>
<ref id="B11">
<label>11</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mackenzie</surname> <given-names>CD</given-names>
</name>
</person-group>. <article-title>Eosinophil leucocytes in filarial infections</article-title>. <source>Trans R Soc Trop Med Hygiene</source> (<year>1980</year>) <volume>74</volume>:<page-range>51&#x2013;8</page-range>. doi: <pub-id pub-id-type="doi">10.1016/0035-9203(80)90273-4</pub-id>
</citation>
</ref>
<ref id="B12">
<label>12</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pionnier</surname> <given-names>N</given-names>
</name>
<name>
<surname>Sjoberg</surname> <given-names>H</given-names>
</name>
<name>
<surname>Furlong-Silva</surname> <given-names>J</given-names>
</name>
<name>
<surname>Marriott</surname> <given-names>A</given-names>
</name>
<name>
<surname>Halliday</surname> <given-names>A</given-names>
</name>
<name>
<surname>Archer</surname> <given-names>J</given-names>
</name>
<etal/>
</person-group>. <article-title>Eosinophil-mediated immune control of adult filarial nematode infection can proceed in the absence of IL-4 receptor signaling</article-title>. <source>J Immunol</source> (<year>2020</year>) <volume>205</volume>:<fpage>731</fpage>. doi: <pub-id pub-id-type="doi">10.4049/jimmunol.1901244</pub-id>
</citation>
</ref>
<ref id="B13">
<label>13</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Turner</surname> <given-names>JD</given-names>
</name>
<name>
<surname>Pionnier</surname> <given-names>N</given-names>
</name>
<name>
<surname>Furlong-Silva</surname> <given-names>J</given-names>
</name>
<name>
<surname>Sjoberg</surname> <given-names>H</given-names>
</name>
<name>
<surname>Cross</surname> <given-names>S</given-names>
</name>
<name>
<surname>Halliday</surname> <given-names>A</given-names>
</name>
<etal/>
</person-group>. <article-title>Interleukin-4 activated macrophages mediate immunity to filarial helminth infection by sustaining CCR3-dependent eosinophilia</article-title>. <source>PloS Pathog</source> (<year>2018</year>) <volume>14</volume>:<elocation-id>e1006949</elocation-id>. doi: <pub-id pub-id-type="doi">10.1371/journal.ppat.1006949</pub-id>
</citation>
</ref>
<ref id="B14">
<label>14</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Capron</surname> <given-names>M</given-names>
</name>
</person-group>. <article-title>Dual function of eosinophils in pathogenesis and protective immunity against parasites</article-title>. <source>Mem Inst Oswaldo Cruz</source> (<year>1992</year>) <volume>87</volume>:<page-range>83&#x2013;9</page-range>. doi: <pub-id pub-id-type="doi">10.1590/S0074-02761992000900012</pub-id>
</citation>
</ref>
<ref id="B15">
<label>15</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hamann</surname> <given-names>KJ</given-names>
</name>
<name>
<surname>Gleich</surname> <given-names>GJ</given-names>
</name>
<name>
<surname>Checkel</surname> <given-names>JL</given-names>
</name>
<name>
<surname>Loegering</surname> <given-names>DA</given-names>
</name>
<name>
<surname>McCall</surname> <given-names>JW</given-names>
</name>
<name>
<surname>Barker</surname> <given-names>RL</given-names>
</name>
</person-group>. <article-title>
<italic>In vitro</italic> killing of microfilariae of brugia pahangi and brugia malayi by eosinophil granule proteins</article-title>. <source>J Immunol</source> (<year>1990</year>) <volume>144</volume>:<fpage>3166</fpage>.</citation>
</ref>
<ref id="B16">
<label>16</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Makepeace</surname> <given-names>BL</given-names>
</name>
<name>
<surname>Martin</surname> <given-names>C</given-names>
</name>
<name>
<surname>Turner</surname> <given-names>JD</given-names>
</name>
<name>
<surname>Specht</surname> <given-names>S</given-names>
</name>
</person-group>. <article-title>Granulocytes in helminth infection - who is calling the shots</article-title>? <source>Curr medicinal Chem</source> (<year>2012</year>) <volume>19</volume>:<page-range>1567&#x2013;86</page-range>. doi: <pub-id pub-id-type="doi">10.2174/092986712799828337</pub-id>
</citation>
</ref>
<ref id="B17">
<label>17</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Attout</surname> <given-names>T</given-names>
</name>
<name>
<surname>Martin</surname> <given-names>C</given-names>
</name>
<name>
<surname>Babayan</surname> <given-names>SA</given-names>
</name>
<name>
<surname>Kozek</surname> <given-names>WJ</given-names>
</name>
<name>
<surname>Bazzocchi</surname> <given-names>C</given-names>
</name>
<name>
<surname>Oudet</surname> <given-names>F</given-names>
</name>
<etal/>
</person-group>. <article-title>Pleural cellular reaction to the filarial infection litomosoides sigmodontis is determined by the moulting process, the worm alteration, and the host strain</article-title>. <source>Parasitol Int</source> (<year>2008</year>) <volume>57</volume>:<page-range>201&#x2013;11</page-range>. doi: <pub-id pub-id-type="doi">10.1016/j.parint.2008.01.001</pub-id>
</citation>
</ref>
<ref id="B18">
<label>18</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vivier</surname> <given-names>E</given-names>
</name>
<name>
<surname>Artis</surname> <given-names>D</given-names>
</name>
<name>
<surname>Colonna</surname> <given-names>M</given-names>
</name>
<name>
<surname>Diefenbach</surname> <given-names>A</given-names>
</name>
<name>
<surname>Di Santo</surname> <given-names>JP</given-names>
</name>
<name>
<surname>Eberl</surname> <given-names>G</given-names>
</name>
<etal/>
</person-group>. <article-title>Innate lymphoid cells: 10 years on</article-title>. <source>Cell</source> (<year>2018</year>) <volume>174</volume>:<page-range>1054&#x2013;66</page-range>. doi: <pub-id pub-id-type="doi">10.1016/j.cell.2018.07.017</pub-id>
</citation>
</ref>
<ref id="B19">
<label>19</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Eberl</surname> <given-names>G</given-names>
</name>
<name>
<surname>Colonna</surname> <given-names>M</given-names>
</name>
<name>
<surname>Di Santo James</surname> <given-names>P</given-names>
</name>
<name>
<surname>McKenzie Andrew</surname> <given-names>NJ</given-names>
</name>
</person-group>. <article-title>Innate lymphoid cells: A new paradigm in immunology</article-title>. <source>Science</source> (<year>2015</year>) <volume>348</volume>:<fpage>aaa6566</fpage>. doi: <pub-id pub-id-type="doi">10.1126/science.aaa6566</pub-id>
</citation>
</ref>
<ref id="B20">
<label>20</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Boyd</surname> <given-names>A</given-names>
</name>
<name>
<surname>Killoran</surname> <given-names>K</given-names>
</name>
<name>
<surname>Mitre</surname> <given-names>E</given-names>
</name>
<name>
<surname>Nutman</surname> <given-names>TB</given-names>
</name>
</person-group>. <article-title>Pleural cavity type 2 innate lymphoid cells precede Th2 expansion in murine litomosoides sigmodontis infection</article-title>. <source>Exp Parasitol</source> (<year>2015</year>) <volume>159</volume>:<page-range>118&#x2013;26</page-range>. doi: <pub-id pub-id-type="doi">10.1016/j.exppara.2015.09.006</pub-id>
</citation>
</ref>
<ref id="B21">
<label>21</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Molofsky</surname> <given-names>AB</given-names>
</name>
<name>
<surname>Nussbaum</surname> <given-names>JC</given-names>
</name>
<name>
<surname>Liang</surname> <given-names>HE</given-names>
</name>
<name>
<surname>Van Dyken</surname> <given-names>SJ</given-names>
</name>
<name>
<surname>Cheng</surname> <given-names>LE</given-names>
</name>
<name>
<surname>Mohapatra</surname> <given-names>A</given-names>
</name>
<etal/>
</person-group>. <article-title>Innate lymphoid type 2 cells sustain visceral adipose tissue eosinophils and alternatively activated macrophages</article-title>. <source>J Exp Med</source> (<year>2013</year>) <volume>210</volume>:<page-range>535&#x2013;49</page-range>. doi: <pub-id pub-id-type="doi">10.1084/jem.20121964</pub-id>
</citation>
</ref>
<ref id="B22">
<label>22</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pelly</surname> <given-names>VS</given-names>
</name>
<name>
<surname>Kannan</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Coomes</surname> <given-names>SM</given-names>
</name>
<name>
<surname>Entwistle</surname> <given-names>LJ</given-names>
</name>
<name>
<surname>R&#xfc;ckerl</surname> <given-names>D</given-names>
</name>
<name>
<surname>Seddon</surname> <given-names>B</given-names>
</name>
<etal/>
</person-group>. <article-title>IL-4-producing ILC2s are required for the differentiation of T(H)2 cells following heligmosomoides polygyrus infection</article-title>. <source>Mucosal Immunol</source> (<year>2016</year>) <volume>9</volume>:<page-range>1407&#x2013;17</page-range>. doi: <pub-id pub-id-type="doi">10.1038/mi.2016.4</pub-id>
</citation>
</ref>
<ref id="B23">
<label>23</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Layland</surname> <given-names>LE</given-names>
</name>
<name>
<surname>Ajendra</surname> <given-names>J</given-names>
</name>
<name>
<surname>Ritter</surname> <given-names>M</given-names>
</name>
<name>
<surname>Wiszniewsky</surname> <given-names>A</given-names>
</name>
<name>
<surname>Hoerauf</surname> <given-names>A</given-names>
</name>
<name>
<surname>H&#xfc;bner</surname> <given-names>MP</given-names>
</name>
</person-group>. <article-title>Development of patent litomosoides sigmodontis infections in semi-susceptible C57BL/6 mice in the absence of adaptive immune responses</article-title>. <source>Parasites Vectors</source> (<year>2015</year>) <volume>8</volume>:<fpage>396</fpage>. doi: <pub-id pub-id-type="doi">10.1186/s13071-015-1011-2</pub-id>
</citation>
</ref>
<ref id="B24">
<label>24</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wiszniewsky</surname> <given-names>A</given-names>
</name>
<name>
<surname>Layland</surname> <given-names>LE</given-names>
</name>
<name>
<surname>Arndts</surname> <given-names>K</given-names>
</name>
<name>
<surname>Wadephul</surname> <given-names>LM</given-names>
</name>
<name>
<surname>Tamadaho</surname> <given-names>RSE</given-names>
</name>
<name>
<surname>Borrero-Wolff</surname> <given-names>D</given-names>
</name>
<etal/>
</person-group>. <article-title>Adoptive transfer of immune cells into RAG2IL-2R&#x3b3;-Deficient mice during litomosoides sigmodontis infection: A novel approach to investigate filarial-specific immune responses</article-title>. <source>Front Immunol</source> (<year>2021</year>) <volume>12</volume>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fimmu.2021.777860</pub-id>
</citation>
</ref>
<ref id="B25">
<label>25</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pionnier</surname> <given-names>NP</given-names>
</name>
<name>
<surname>Sjoberg</surname> <given-names>H</given-names>
</name>
<name>
<surname>Chunda</surname> <given-names>VC</given-names>
</name>
<name>
<surname>Fombad</surname> <given-names>FF</given-names>
</name>
<name>
<surname>Chounna</surname> <given-names>PW</given-names>
</name>
<name>
<surname>Njouendou</surname> <given-names>AJ</given-names>
</name>
<etal/>
</person-group>. <article-title>Mouse models of loa loa</article-title>. <source>Nat Commun</source> (<year>2019</year>) <volume>10</volume>:<page-range>1429&#x2013;9</page-range>. doi: <pub-id pub-id-type="doi">10.1038/s41467-019-09442-0</pub-id>
</citation>
</ref>
<ref id="B26">
<label>26</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Babu</surname> <given-names>S</given-names>
</name>
<name>
<surname>Blauvelt Cp Fau - Nutman</surname> <given-names>TB</given-names>
</name>
<name>
<surname>Nutman</surname> <given-names>TB</given-names>
</name>
</person-group>. <article-title>Filarial parasites induce NK cell activation, type 1 and type 2 cytokine secretion, and subsequent apoptotic cell death</article-title>. <source>J Immunol</source> (<year>2007</year>) <volume>179</volume>(<issue>4</issue>):<page-range>2445&#x2013;56</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.4049/jimmunol.179.4.2445</pub-id>
</citation>
</ref>
<ref id="B27">
<label>27</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hepworth</surname> <given-names>MR</given-names>
</name>
<name>
<surname>Grencis</surname> <given-names>RK</given-names>
</name>
</person-group>. <article-title>Disruption of Th2 immunity results in a gender-specific expansion of IL-13 producing accessory NK cells during helminth infection</article-title>. <source>J Immunol</source> (<year>2009</year>) <volume>183</volume>:<fpage>3906</fpage>. doi: <pub-id pub-id-type="doi">10.4049/jimmunol.0900577</pub-id>
</citation>
</ref>
<ref id="B28">
<label>28</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Korten</surname> <given-names>S</given-names>
</name>
<name>
<surname>Volkmann L Fau - Saeftel</surname> <given-names>M</given-names>
</name>
<name>
<surname>Saeftel M Fau - Fischer</surname> <given-names>K</given-names>
</name>
<name>
<surname>Fischer K Fau - Taniguchi</surname> <given-names>M</given-names>
</name>
<name>
<surname>Taniguchi M Fau - Fleischer</surname> <given-names>B</given-names>
</name>
<name>
<surname>Fleischer B Fau - Hoerauf</surname> <given-names>A</given-names>
</name>
<etal/>
</person-group>. <article-title>Expansion of NK cells with reduction of their inhibitory ly-49A, ly-49C, and ly-49G2 receptor-expressing subsets in a murine helminth infection: contribution to parasite control</article-title>. <source>J Immunol</source> (<year>2002</year>) <volume>168</volume> (<issue>10</issue>):<page-range>5199&#x2013;206</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.4049/jimmunol.168.10.5199</pub-id>
</citation>
</ref>
<ref id="B29">
<label>29</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Halliday</surname> <given-names>A</given-names>
</name>
<name>
<surname>Guimaraes</surname> <given-names>AF</given-names>
</name>
<name>
<surname>Tyrer</surname> <given-names>HE</given-names>
</name>
<name>
<surname>Metuge</surname> <given-names>HM</given-names>
</name>
<name>
<surname>Patrick</surname> <given-names>CN</given-names>
</name>
<name>
<surname>Arnaud</surname> <given-names>KO</given-names>
</name>
<etal/>
</person-group>. <article-title>A murine macrofilaricide pre-clinical screening model for onchocerciasis and lymphatic filariasis</article-title>. <source>Parasit Vectors</source> (<year>2014</year>) <volume>7</volume>:<fpage>472</fpage>. doi: <pub-id pub-id-type="doi">10.1186/s13071-014-0472-z</pub-id>
</citation>
</ref>
<ref id="B30">
<label>30</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sjoberg</surname> <given-names>HT</given-names>
</name>
<name>
<surname>Pionnier</surname> <given-names>N</given-names>
</name>
<name>
<surname>Aljayyoussi</surname> <given-names>G</given-names>
</name>
<name>
<surname>Metuge</surname> <given-names>HM</given-names>
</name>
<name>
<surname>Njouendou</surname> <given-names>AJ</given-names>
</name>
<name>
<surname>Chunda</surname> <given-names>VC</given-names>
</name>
<etal/>
</person-group>. <article-title>Short-course, oral flubendazole does not mediate significant efficacy against onchocerca adult male worms or brugia microfilariae in murine infection models</article-title>. <source>PloS Negl Trop Dis</source> (<year>2019</year>) <volume>13</volume>:<elocation-id>e0006356</elocation-id>. doi: <pub-id pub-id-type="doi">10.1371/journal.pntd.0006356</pub-id>
</citation>
</ref>
<ref id="B31">
<label>31</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mackenzie</surname> <given-names>CD</given-names>
</name>
<name>
<surname>Geary</surname> <given-names>TG</given-names>
</name>
</person-group>. <article-title>Flubendazole: A candidate macrofilaricide for lymphatic filariasis and onchocerciasis field programs</article-title>. <source>Expert Rev Anti Infect Ther</source> (<year>2011</year>) <volume>9</volume>:<fpage>497</fpage>&#x2013;<lpage>501</lpage>. doi: <pub-id pub-id-type="doi">10.1586/eri.11.30</pub-id>
</citation>
</ref>
<ref id="B32">
<label>32</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Denham</surname> <given-names>DA</given-names>
</name>
<name>
<surname>Samad</surname> <given-names>R</given-names>
</name>
<name>
<surname>Cho</surname> <given-names>SY</given-names>
</name>
<name>
<surname>Suswillo</surname> <given-names>RR</given-names>
</name>
<name>
<surname>Skippins</surname> <given-names>SC</given-names>
</name>
</person-group>. <article-title>The anthelmintic effects of flubendazole on brugia pahangi</article-title>. <source>Trans R Soc Trop Med Hyg</source> (<year>1979</year>) <volume>73</volume>:<page-range>673&#x2013;6</page-range>. doi: <pub-id pub-id-type="doi">10.1016/0035-9203(79)90018-X</pub-id>
</citation>
</ref>
<ref id="B33">
<label>33</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Smith</surname> <given-names>KA</given-names>
</name>
<name>
<surname>L&#xf6;ser</surname> <given-names>S</given-names>
</name>
<name>
<surname>Varyani</surname> <given-names>F</given-names>
</name>
<name>
<surname>Harcus</surname> <given-names>Y</given-names>
</name>
<name>
<surname>McSorley</surname> <given-names>HJ</given-names>
</name>
<name>
<surname>McKenzie</surname> <given-names>ANJ</given-names>
</name>
<etal/>
</person-group>. <article-title>Concerted IL-25R and IL-4R&#x3b1; signaling drive innate type 2 effector immunity for optimal helminth expulsion</article-title>. <source>eLife</source> (<year>2018</year>) <volume>7</volume>:<elocation-id>e38269</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.7554/eLife.38269</pub-id>
</citation>
</ref>
<ref id="B34">
<label>34</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Neill</surname> <given-names>DR</given-names>
</name>
<name>
<surname>Wong</surname> <given-names>SH</given-names>
</name>
<name>
<surname>Bellosi</surname> <given-names>A</given-names>
</name>
<name>
<surname>Flynn</surname> <given-names>RJ</given-names>
</name>
<name>
<surname>Daly</surname> <given-names>M</given-names>
</name>
<name>
<surname>Langford</surname> <given-names>TKA</given-names>
</name>
<etal/>
</person-group>. <article-title>Nuocytes represent a new innate effector leukocyte that mediates type-2 immunity</article-title>. <source>Nature</source> (<year>2010</year>) <volume>464</volume>:<page-range>1367&#x2013;70</page-range>. doi: <pub-id pub-id-type="doi">10.1038/nature08900</pub-id>
</citation>
</ref>
<ref id="B35">
<label>35</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yoshino</surname> <given-names>H</given-names>
</name>
<name>
<surname>Ueda</surname> <given-names>T</given-names>
</name>
<name>
<surname>Kawahata</surname> <given-names>M</given-names>
</name>
<name>
<surname>Kobayashi</surname> <given-names>K</given-names>
</name>
<name>
<surname>Ebihara</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Manabe</surname> <given-names>A</given-names>
</name>
<etal/>
</person-group>. <article-title>Natural killer cell depletion by anti-asialo GM1 antiserum treatment enhances human hematopoietic stem cell engraftment in NOD/Shi-scid mice</article-title>. <source>Bone Marrow Transplant</source> (<year>2000</year>) <volume>26</volume>:<page-range>1211&#x2013;6</page-range>. doi: <pub-id pub-id-type="doi">10.1038/sj.bmt.1702702</pub-id>
</citation>
</ref>
<ref id="B36">
<label>36</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kiniwa</surname> <given-names>T</given-names>
</name>
<name>
<surname>Enomoto</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Terazawa</surname> <given-names>N</given-names>
</name>
<name>
<surname>Omi</surname> <given-names>A</given-names>
</name>
<name>
<surname>Miyata</surname> <given-names>N</given-names>
</name>
<name>
<surname>Ishiwata</surname> <given-names>K</given-names>
</name>
<etal/>
</person-group>. <article-title>NK cells activated by interleukin-4 in cooperation with interleukin-15 exhibit distinctive characteristics</article-title>. <source>Proc Natl Acad Sci</source> (<year>2016</year>) <volume>113</volume>:<fpage>10139</fpage>. doi: <pub-id pub-id-type="doi">10.1073/pnas.1600112113</pub-id>
</citation>
</ref>
<ref id="B37">
<label>37</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Walzer</surname> <given-names>T</given-names>
</name>
<name>
<surname>Bl&#xe9;ry</surname> <given-names>M</given-names>
</name>
<name>
<surname>Chaix</surname> <given-names>J</given-names>
</name>
<name>
<surname>Fuseri</surname> <given-names>N</given-names>
</name>
<name>
<surname>Chasson</surname> <given-names>L</given-names>
</name>
<name>
<surname>Robbins</surname> <given-names>SH</given-names>
</name>
<etal/>
</person-group>. <article-title>Identification, activation, and selective <italic>in vivo</italic> ablation of mouse NK cells <italic>via</italic> NKp46</article-title>. <source>Proc Natl Acad Sci USA</source> (<year>2007</year>) <volume>104</volume>:<page-range>3384&#x2013;9</page-range>. doi: <pub-id pub-id-type="doi">10.1073/pnas.0609692104</pub-id>
</citation>
</ref>
<ref id="B38">
<label>38</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Netea</surname> <given-names>MG</given-names>
</name>
<name>
<surname>Joosten</surname> <given-names>LAB</given-names>
</name>
<name>
<surname>Latz</surname> <given-names>E</given-names>
</name>
<name>
<surname>Mills</surname> <given-names>KHG</given-names>
</name>
<name>
<surname>Natoli</surname> <given-names>G</given-names>
</name>
<name>
<surname>Stunnenberg</surname> <given-names>HG</given-names>
</name>
<etal/>
</person-group>. <article-title>Trained immunity: A program of innate immune memory in health and disease</article-title>. <source>Sci (New York N.Y.)</source> (<year>2016</year>) <volume>352</volume>:<fpage>aaf1098</fpage>&#x2013;<lpage>aaf1098</lpage>. doi: <pub-id pub-id-type="doi">10.1126/science.aaf1098</pub-id>
</citation>
</ref>
<ref id="B39">
<label>39</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cerwenka</surname> <given-names>A</given-names>
</name>
<name>
<surname>Lanier</surname> <given-names>LL</given-names>
</name>
</person-group>. <article-title>Natural killer cell memory in infection, inflammation and cancer</article-title>. <source>Nat Rev Immunol</source> (<year>2016</year>) <volume>16</volume>:<page-range>112&#x2013;23</page-range>. doi: <pub-id pub-id-type="doi">10.1038/nri.2015.9</pub-id>
</citation>
</ref>
<ref id="B40">
<label>40</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Peng</surname> <given-names>H</given-names>
</name>
<name>
<surname>Tian</surname> <given-names>Z</given-names>
</name>
</person-group>. <article-title>Natural killer cell memory: Progress and implications</article-title>. <source>Front Immunol</source> (<year>2017</year>) <volume>8</volume>:<page-range>1143&#x2013;3</page-range>. doi: <pub-id pub-id-type="doi">10.3389/fimmu.2017.01143</pub-id>
</citation>
</ref>
<ref id="B41">
<label>41</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Aravindhan</surname> <given-names>V</given-names>
</name>
<name>
<surname>Anand</surname> <given-names>G</given-names>
</name>
</person-group>. <article-title>Cell type-specific immunomodulation induced by helminthes: Effect on metainflammation, insulin resistance and type-2 diabetes</article-title>. <source>Am J Trop Med hygiene</source> (<year>2017</year>) <volume>97</volume>:<page-range>1650&#x2013;61</page-range>. doi: <pub-id pub-id-type="doi">10.4269/ajtmh.17-0236</pub-id>
</citation>
</ref>
<ref id="B42">
<label>42</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nish</surname> <given-names>S</given-names>
</name>
<name>
<surname>Medzhitov</surname> <given-names>R</given-names>
</name>
</person-group>. <article-title>Host defense pathways: Role of redundancy and compensation in infectious disease phenotypes</article-title>. <source>Immunity</source> (<year>2011</year>) <volume>34</volume>:<page-range>629&#x2013;36</page-range>. doi: <pub-id pub-id-type="doi">10.1016/j.immuni.2011.05.009</pub-id>
</citation>
</ref>
<ref id="B43">
<label>43</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Babu</surname> <given-names>S</given-names>
</name>
<name>
<surname>Porte</surname> <given-names>P</given-names>
</name>
<name>
<surname>Klei</surname> <given-names>TR</given-names>
</name>
<name>
<surname>Shultz</surname> <given-names>LD</given-names>
</name>
<name>
<surname>Rajan</surname> <given-names>TV</given-names>
</name>
</person-group>. <article-title>Host NK cells are required for the growth of the human filarial parasite Brugia malayi in mice</article-title>. <source>J Immunol</source> (<year>1998</year>) <volume>161</volume>(<issue>3</issue>):<page-range>1428&#x2013;32</page-range>.</citation>
</ref>
<ref id="B44">
<label>44</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Folkard</surname> <given-names>SG</given-names>
</name>
<name>
<surname>Taylor</surname> <given-names>MJ</given-names>
</name>
<name>
<surname>Butcher</surname> <given-names>GA</given-names>
</name>
<name>
<surname>Bianco</surname> <given-names>AE</given-names>
</name>
</person-group>. <article-title>Protective responses against skin-dwelling microfilariae of onchocerca lienalis in severe combined immunodeficient mice</article-title>. <source>Infection Immun</source> (<year>1997</year>) <volume>65</volume>:<page-range>2846&#x2013;51</page-range>. doi: <pub-id pub-id-type="doi">10.1128/iai.65.7.2846-2851.1997</pub-id>
</citation>
</ref>
<ref id="B45">
<label>45</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ehrens</surname> <given-names>A</given-names>
</name>
<name>
<surname>Lenz</surname> <given-names>B</given-names>
</name>
<name>
<surname>Neumann</surname> <given-names>A-L</given-names>
</name>
<name>
<surname>Giarrizzo</surname> <given-names>S</given-names>
</name>
<name>
<surname>Reichwald</surname> <given-names>JJ</given-names>
</name>
<name>
<surname>Frohberger</surname> <given-names>SJ</given-names>
</name>
<etal/>
</person-group>. <article-title>Microfilariae trigger eosinophil extracellular DNA traps in a dectin-1-Dependent manner</article-title>. <source>Cell Rep</source> (<year>2021</year>) <volume>34</volume>:<fpage>108621</fpage>. doi: <pub-id pub-id-type="doi">10.1016/j.celrep.2020.108621</pub-id>
</citation>
</ref>
<ref id="B46">
<label>46</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pionnier</surname> <given-names>N</given-names>
</name>
<name>
<surname>Brotin</surname> <given-names>E</given-names>
</name>
<name>
<surname>Karadjian</surname> <given-names>G</given-names>
</name>
<name>
<surname>Hemon</surname> <given-names>P</given-names>
</name>
<name>
<surname>Gaudin-Nom&#xe9;</surname> <given-names>F</given-names>
</name>
<name>
<surname>Vallarino-Lhermitte</surname> <given-names>N</given-names>
</name>
<etal/>
</person-group>. <article-title>Neutropenic mice provide insight into the role of skin-infiltrating neutrophils in the host protective immunity against filarial infective larvae</article-title>. <source>PloS Negl Trop Dis</source> (<year>2016</year>) <volume>10</volume>:<fpage>e0004605</fpage>&#x2013;<lpage>e0004605</lpage>. doi: <pub-id pub-id-type="doi">10.1371/journal.pntd.0004605</pub-id>
</citation>
</ref>
<ref id="B47">
<label>47</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nishikado</surname> <given-names>H</given-names>
</name>
<name>
<surname>Mukai K, Kawano</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Minegishi</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Karasuyama</surname> <given-names>H</given-names>
</name>
</person-group>. <article-title>NK cell-depleting anti-asialo GM1 antibody exhibits a lethal off-target effect on basophils <italic>in vivo</italic>
</article-title>. <source>J Immunol</source>. (<year>2011</year>) <volume>186</volume>(<issue>10</issue>):<page-range>5766&#x2013;71</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.4049/jimmunol.1100370</pub-id>
</citation>
</ref>
<ref id="B48">
<label>48</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Narni-Mancinelli</surname> <given-names>E</given-names>
</name>
<name>
<surname>Jaeger Bn Fau - Bernat</surname> <given-names>C</given-names>
</name>
<name>
<surname>Bernat C Fau - Fenis</surname> <given-names>A</given-names>
</name>
<name>
<surname>Fenis A Fau - Kung</surname> <given-names>S</given-names>
</name>
<name>
<surname>Kung S Fau - De Gassart</surname> <given-names>A</given-names>
</name>
<name>
<surname>De Gassart A Fau - Mahmood</surname> <given-names>S</given-names>
</name>
<etal/>
</person-group>. <article-title>Tuning of natural killer cell reactivity by NKp46 and Helios calibrates T cell responses</article-title>. <source>Science</source> (<year>2012</year>) <volume>335</volume>(<issue>6066</issue>):<page-range>344&#x2013;8</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1126/science.1215621</pub-id>
</citation>
</ref>
<ref id="B49">
<label>49</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Torrero</surname> <given-names>MN</given-names>
</name>
<name>
<surname>H&#xfc;bner</surname> <given-names>MP</given-names>
</name>
<name>
<surname>Larson</surname> <given-names>D</given-names>
</name>
<name>
<surname>Karasuyama</surname> <given-names>H</given-names>
</name>
<name>
<surname>Mitre</surname> <given-names>E</given-names>
</name>
</person-group>. <article-title>Basophils amplify type 2 immune responses, but do not serve a protective role, during chronic infection of mice with the filarial nematode &amp;lt;em&lt;Litomosoides sigmodontis&amp;lt;/em&amp;gt</article-title>. <source>J Immunol</source> (<year>2010</year>) <volume>185</volume>:<fpage>7426</fpage>. doi: <pub-id pub-id-type="doi">10.4049/jimmunol.0903864</pub-id>
</citation>
</ref>
<ref id="B50">
<label>50</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Barnig</surname> <given-names>C</given-names>
</name>
<name>
<surname>Cernadas</surname> <given-names>M</given-names>
</name>
<name>
<surname>Dutile</surname> <given-names>S</given-names>
</name>
<name>
<surname>Liu</surname> <given-names>X</given-names>
</name>
<name>
<surname>Perrella</surname> <given-names>MA</given-names>
</name>
<name>
<surname>Kazani</surname> <given-names>S</given-names>
</name>
<etal/>
</person-group>. <article-title>Lipoxin A4 regulates natural killer cell and type 2 innate lymphoid cell activation in asthma</article-title>. <source>Sci Trans Med</source> (<year>2013</year>) <volume>5</volume>:<fpage>174ra126</fpage>&#x2013;<lpage>174ra126</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1126/scitranslmed.3004812</pub-id>
</citation>
</ref>
<ref id="B51">
<label>51</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Korsgren</surname> <given-names>M</given-names>
</name>
<name>
<surname>Persson</surname> <given-names>CG</given-names>
</name>
<name>
<surname>Sundler</surname> <given-names>F</given-names>
</name>
<name>
<surname>Bjerke</surname> <given-names>T</given-names>
</name>
<name>
<surname>Hansson</surname> <given-names>T</given-names>
</name>
<name>
<surname>Chambers</surname> <given-names>BJ</given-names>
</name>
<etal/>
</person-group>. <article-title>Natural killer cells determine development of allergen-induced eosinophilic airway inflammation in mice</article-title>. <source>J Exp Med</source> (<year>1999</year>) <volume>189</volume>:<page-range>553&#x2013;62</page-range>. doi: <pub-id pub-id-type="doi">10.1084/jem.189.3.553</pub-id>
</citation>
</ref>
<ref id="B52">
<label>52</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ple</surname> <given-names>C</given-names>
</name>
<name>
<surname>Barrier M, Amniai</surname> <given-names>L</given-names>
</name>
<name>
<surname>Marquillies</surname> <given-names>P</given-names>
</name>
<name>
<surname>Bertout</surname> <given-names>J</given-names>
</name>
<name>
<surname>Tsicopoulos</surname> <given-names>A</given-names>
</name>
<etal/>
</person-group>. <article-title>Natural killer cells accumulate in lung-draining lymph nodes and regulate airway eosinophilia in a murine model of asthma</article-title>. <source>Scand J Immunol</source>. (<year>2010</year>) <volume>72</volume>(<issue>2</issue>):<page-range>118&#x2013;27</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1111/j.1365-3083.2010.02419.x</pub-id>
</citation>
</ref>
<ref id="B53">
<label>53</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Awad</surname> <given-names>A</given-names>
</name>
<name>
<surname>Yassine</surname> <given-names>H</given-names>
</name>
<name>
<surname>Barrier</surname> <given-names>M</given-names>
</name>
<name>
<surname>Vorng</surname> <given-names>H</given-names>
</name>
<name>
<surname>Marquillies</surname> <given-names>P</given-names>
</name>
<name>
<surname>Tsicopoulos</surname> <given-names>A</given-names>
</name>
<etal/>
</person-group>. <article-title>Natural killer cells induce eosinophil activation and apoptosis</article-title>. <source>PloS One</source> (<year>2014</year>) <volume>9</volume>:<page-range>e94492&#x2013;2</page-range>. doi: <pub-id pub-id-type="doi">10.1371/journal.pone.0094492</pub-id>
</citation>
</ref>
<ref id="B54">
<label>54</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Haworth</surname> <given-names>O</given-names>
</name>
<name>
<surname>Cernadas</surname> <given-names>M</given-names>
</name>
<name>
<surname>Levy</surname> <given-names>BD</given-names>
</name>
</person-group>. <article-title>NK cells are effectors for resolvin E1 in the timely resolution of allergic airway inflammation</article-title>. <source>J Immunol</source> (<year>2011</year>) <volume>186</volume>:<fpage>6129</fpage>. doi: <pub-id pub-id-type="doi">10.4049/jimmunol.1004007</pub-id>
</citation>
</ref>
<ref id="B55">
<label>55</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>L&#xf6;ser</surname> <given-names>S</given-names>
</name>
<name>
<surname>Smith</surname> <given-names>KA</given-names>
</name>
<name>
<surname>Maizels</surname> <given-names>RM</given-names>
</name>
</person-group>. <article-title>Innate lymphoid cells in helminth infections&#x2013;obligatory or accessory</article-title>? <source>Front Immunol</source> (<year>2019</year>) <volume>10</volume>. doi: <pub-id pub-id-type="doi">10.3389/fimmu.2019.00620</pub-id>
</citation>
</ref>
<ref id="B56">
<label>56</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Oliphant</surname> <given-names>CJ</given-names>
</name>
<name>
<surname>Hwang</surname> <given-names>YY</given-names>
</name>
<name>
<surname>Walker</surname> <given-names>JA</given-names>
</name>
<name>
<surname>Salimi</surname> <given-names>M</given-names>
</name>
<name>
<surname>Wong</surname> <given-names>SH</given-names>
</name>
<name>
<surname>Brewer</surname> <given-names>JM</given-names>
</name>
<etal/>
</person-group>. <article-title>MHCII-mediated dialog between group 2 innate lymphoid cells and CD4(+) T cells potentiates type 2 immunity and promotes parasitic helminth expulsion</article-title>. <source>Immunity</source> (<year>2014</year>) <volume>41</volume>:<page-range>283&#x2013;95</page-range>. doi: <pub-id pub-id-type="doi">10.1016/j.immuni.2014.06.016</pub-id>
</citation>
</ref>
<ref id="B57">
<label>57</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Campbell</surname> <given-names>L</given-names>
</name>
<name>
<surname>Hepworth</surname> <given-names>MR</given-names>
</name>
<name>
<surname>Whittingham-Dowd</surname> <given-names>J</given-names>
</name>
<name>
<surname>Thompson</surname> <given-names>S</given-names>
</name>
<name>
<surname>Bancroft</surname> <given-names>AJ</given-names>
</name>
<name>
<surname>Hayes</surname> <given-names>KS</given-names>
</name>
<etal/>
</person-group>. <article-title>ILC2s mediate systemic innate protection by priming mucus production at distal mucosal sites</article-title>. <source>J Exp Med</source> (<year>2019</year>) <volume>216</volume>:<page-range>2714&#x2013;23</page-range>. doi: <pub-id pub-id-type="doi">10.1084/jem.20180610</pub-id>
</citation>
</ref>
<ref id="B58">
<label>58</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Filbey</surname> <given-names>KJ</given-names>
</name>
<name>
<surname>Camberis</surname> <given-names>M</given-names>
</name>
<name>
<surname>Chandler</surname> <given-names>J</given-names>
</name>
<name>
<surname>Turner</surname> <given-names>R</given-names>
</name>
<name>
<surname>Kettle</surname> <given-names>AJ</given-names>
</name>
<name>
<surname>Eichenberger</surname> <given-names>RM</given-names>
</name>
<etal/>
</person-group>. <article-title>Intestinal helminth infection promotes IL-5- and CD4+ T cell-dependent immunity in the lung against migrating parasites</article-title>. <source>Mucosal Immunol</source> (<year>2019</year>) <volume>12</volume>:<page-range>352&#x2013;62</page-range>. doi: <pub-id pub-id-type="doi">10.1038/s41385-018-0102-8</pub-id>
</citation>
</ref>
<ref id="B59">
<label>59</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Boyd</surname> <given-names>A</given-names>
</name>
<name>
<surname>Ribeiro</surname> <given-names>JMC</given-names>
</name>
<name>
<surname>Nutman</surname> <given-names>TB</given-names>
</name>
</person-group>. <article-title>Human CD117 (cKit)+ innate lymphoid cells have a discrete transcriptional profile at homeostasis and are expanded during filarial infection</article-title>. <source>PloS One</source> (<year>2014</year>) <volume>9</volume>:<elocation-id>e108649</elocation-id>. doi: <pub-id pub-id-type="doi">10.1371/journal.pone.0108649</pub-id>
</citation>
</ref>
<ref id="B60">
<label>60</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ajendra</surname> <given-names>J</given-names>
</name>
<name>
<surname>Specht</surname> <given-names>S</given-names>
</name>
<name>
<surname>Neumann</surname> <given-names>A-L</given-names>
</name>
<name>
<surname>Gondorf</surname> <given-names>F</given-names>
</name>
<name>
<surname>Schmidt</surname> <given-names>D</given-names>
</name>
<name>
<surname>Gentil</surname> <given-names>K</given-names>
</name>
<etal/>
</person-group>. <article-title>ST2 deficiency does not impair type 2 immune responses during chronic filarial infection but leads to an increased microfilaremia due to an impaired splenic microfilarial clearance</article-title>. <source>PloS One</source> (<year>2014</year>) <volume>9</volume>:<page-range>e93072&#x2013;2</page-range>. doi: <pub-id pub-id-type="doi">10.1371/journal.pone.0093072</pub-id>
</citation>
</ref>
<ref id="B61">
<label>61</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Karadjian</surname> <given-names>G</given-names>
</name>
<name>
<surname>Fercoq</surname> <given-names>F</given-names>
</name>
<name>
<surname>Pionnier</surname> <given-names>N</given-names>
</name>
<name>
<surname>Vallarino-Lhermitte</surname> <given-names>N</given-names>
</name>
<name>
<surname>Lefoulon</surname> <given-names>E</given-names>
</name>
<name>
<surname>Nieguitsila</surname> <given-names>A</given-names>
</name>
<etal/>
</person-group>. <article-title>Migratory phase of litomosoides sigmodontis filarial infective larvae is associated with pathology and transient increase of S100A9 expressing neutrophils in the lung</article-title>. <source>PloS Negl Trop Dis</source> (<year>2017</year>) <volume>11</volume>:<elocation-id>e0005596</elocation-id>. doi: <pub-id pub-id-type="doi">10.1371/journal.pntd.0005596</pub-id>
</citation>
</ref>
<ref id="B62">
<label>62</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bouchery</surname> <given-names>T</given-names>
</name>
<name>
<surname>Le Gros</surname> <given-names>G</given-names>
</name>
<name>
<surname>Harris</surname> <given-names>N</given-names>
</name>
</person-group>. <article-title>ILC2s&#x2013;trailblazers in the host response against intestinal helminths</article-title>. <source>Front Immunol</source> (<year>2019</year>) <volume>10</volume>. doi: <pub-id pub-id-type="doi">10.3389/fimmu.2019.00623</pub-id>
</citation>
</ref>
<ref id="B63">
<label>63</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Glover</surname> <given-names>M</given-names>
</name>
<name>
<surname>Colombo</surname> <given-names>SAP</given-names>
</name>
<name>
<surname>Thornton</surname> <given-names>DJ</given-names>
</name>
<name>
<surname>Grencis</surname> <given-names>RK</given-names>
</name>
</person-group>. <article-title>Trickle infection and immunity to trichuris muris</article-title>. <source>PloS Pathog</source> (<year>2019</year>) <volume>15</volume>:<elocation-id>e1007926</elocation-id>. doi: <pub-id pub-id-type="doi">10.1371/journal.ppat.1007926</pub-id>
</citation>
</ref>
<ref id="B64">
<label>64</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Poznanski</surname> <given-names>SM</given-names>
</name>
<name>
<surname>Ashkar</surname> <given-names>AA</given-names>
</name>
</person-group>. <article-title>What defines NK cell functional fate: Phenotype or metabolism</article-title>? <source>Front Immunol</source> (<year>2019</year>) <volume>10</volume>. doi: <pub-id pub-id-type="doi">10.3389/fimmu.2019.01414</pub-id>
</citation>
</ref>
</ref-list>
</back>
</article>